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Abstract
The foreskin is a site of HIV-1 acquisition in heterosexual males. The lack of relevant in
vitro models that mimic the foreskin microenvironment, including innate immune and barrier
functions, has limited our understanding of susceptibility at this site. We hypothesize that we
can establish organotypic in vitro foreskin that mimics in vivo tissue. Organotypic foreskin
models were generated and are composed of stratified cell layers that express E-cadherin
suprabasally, filaggrin apically, and expressed TLR1, TLR2, and β-defensin-1 mRNA similar
to in vivo foreskin. Preliminary results suggest organotypic foreskin tissues retain the ability
to respond to LPS. Lastly, organotypic foreskin permeability appears high when subject to
mechanical agitation. This work has established culture techniques to generate multi-layer
epithelia and the methods necessary to characterize innate immune and barrier functions.
This sets the foundation for future work to fully develop the model, including integrating
immune cells, the microbiota, or HIV-1.
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Summary for Lay Audience
The foreskin creates a fold of skin that provides an environment where bacteria intolerant to
oxygen (known as anaerobes) can live. These anaerobes have been linked to the risk of
acquiring human immunodeficiency virus (HIV) in heterosexual men. Our group has shown
that anaerobes may increase HIV risk by causing local foreskin inflammation (an immune
response) while disrupting foreskin permeability. This could allow HIV to penetrate the
foreskin and infect immune cells (HIVs target cell type) that have gathered in the area due to
this inflammation.
To discern how bacteria mechanistically alter susceptibility to HIV, we propose creation of
an artificial foreskin that mimics natural foreskin in structure and function. Cells will be
isolated from donor foreskins and grown on top of one another to generate layers of the skin.
The artificial foreskin will be characterized next to the donor foreskin to see if it successfully
mimics important aspects of the skin, such as the ability to detect and respond to bacteria on
its surface and form a barrier to the outside environment.
In this study, artificial foreskins were generated that mimicked the structure of the natural
foreskin, such as being composed of multiple cell layers stacked on top of one another.
Tissues also expressed structural proteins commonly found in the natural foreskin such as Ecadherin (helps attach cells together) and filaggrin (helps in developing and maintaining the
outer barrier of the skin). Similar to natural foreskin, artificial foreskins maintained gene
expression of microbe sensors Toll-like Receptor 1 and 2, and antimicrobial protein βdefensin-1. Preliminary data suggests they may be able to respond to stimulation with a
bacterial ligand. Lastly, data suggests that mechanical shaking during tissue development
results in disorganized organotypic foreskin tissue structure with increased permeability.
This body of work has established culture conditions to isolate and propagate primary
keratinocytes from adult foreskin tissue and use these to generate organotypic foreskin
tissues. These tissues show multilayer stratification and differentiation, and expression of
innate immune molecules and barrier proteins. These important developmental steps lay the
groundwork for full model characterization, eventual incorporation of anaerobes, and
challenge with HIV-1.
iii
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Chapter 1

1

Introduction

Human immunodeficiency virus type 1 (HIV-1) is a lentiviral species identified as the
causative agent of acquired immunodeficiency syndrome (AIDS)1–5. Approximately 38
million people across the world were living with HIV in 2019, with 1.9 million new
infections that year alone6. Up to 33 million people have died since the start of the HIV
epidemic, with 690,000 having died as a result of HIV/AIDS in 20196,7. HIV most
heavily impacts sub-Saharan Africa, where it is the leading cause of morbidity and
mortality8,9. HIV acts to compromise the adaptive immune system by infecting and
killing cluster of differentiation 4 positive (CD4+) T cells, leading to AIDS10. This
condition is marked by (1) an inability to fight against and (2) heightened susceptibility
towards otherwise rare opportunistic infections or cancers5,11. After HIV infection is
established, AIDS will typically develop within one decade and after the onset of AIDS,
one- and five-year survival rates are 76% and 46% respectively12. As of 2021, there is no
cure for HIV: infected individuals must undertake lifelong antiretroviral therapy (ART)
to prevent AIDS onset, virus transmission, and permit a relatively normal lifespan4,13–16.
Regrettably, ART is prohibitively expensive ($15,552 Canadian Dollars per person per
year) and adherence difficult, which puts a significant burden on poorer regions of the
world where HIV is most prevalent17–29. Understanding this, it is imperative that novel
and efficacious methods of preventing HIV transmission and acquisition are developed.

1.1

Study Overview

HIV can be transmitted in three ways. This includes through parenteral routes common
with injection drug use-based needle sharing, sexual contact, and through maternal-infant
exposure30. Most HIV infections are the result of sexual exposure, which accounts for
approximately 80% of total infections31. This is in stark contrast with both parenteral and
mother-to-child transmission, which account for the remaining 20%31. Transmission via
sexual contact, despite being the root cause of most HIV infections, is extremely
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inefficient. The probability of male-to-female HIV transmission between serodiscordant
partners is estimated to be around 1:200 to 1:2,000 per sex act, while female-to-male
transmission is estimated at 1:700 to 1:3,00032. The inefficiency of transmission through
sexual contact can be attributed to two factors: variable infectiousness of the HIVinfected partner, and the variable susceptibility of the uninfected partner. The
infectiousness of a partner is the result of the concentration of HIV in one’s blood plasma
and genital secretions (known as the “viral load”), as has been highlighted by research
showing a complete lack of transmission when an infected individual is virally
suppressed with ART33. The variable susceptibility of a non-HIV infected partner has
correlated to a variety of factors, such as age, gender, race, and circumcision status34–38.
Circumcision status has been shown to decrease a heterosexual man’s risk of contracting
HIV by up to 60% in three separate, randomized control studies in Kenya, South Africa,
and Uganda36–38. This protective effect has been correlated with inflammatory markers
and the prevalence of various anaerobic bacteria in the penile subpreputial (underneath
the foreskin) space39–42. Further, strong correlations have been made between six penile
anaerobic species, HIV seroconversion, subpreputial interleukin-8 (IL-8) levels, and
foreskin CD4+ T cell densities in heterosexual men43. It is, however, unclear how
anaerobic bacteria may mechanistically alter HIV susceptibility, as (1) these microbes
frequently co-occur in the subpreputial space, and (2) the studies investigating this
relationship have thus far been observational. Additionally, there exists no relevant in
vitro method to empirically discern the mechanism behind altered HIV transmission at
the level of the foreskin and beyond. This presents a significant barrier in understanding
how HIV is successfully transmitted to heterosexual men and represents a substantial
roadblock in the way of generating new, targeted HIV prevention modalities. This thesis
is the result of work done to generate a relevant tissue model so as to, in the future,
elucidate the how anaerobic subpreputial bacteria mechanistically influence heterosexual
male HIV susceptibility. To do this, I first generated and optimized methods for the
development of a full-depth foreskin equivalent, based on current literature. I then
assessed the ability of this artificial tissue to mimic the innate immune defense
parameters of in vivo foreskin tissues in terms of tissue permeability, pathogen sensors,
and secretion of innate immune factors.
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This introduction will first establish my rationale for examining heterosexual male HIV
susceptibility in relation to the foreskin. Following this, I will examine literature
regarding the penile microbiota in relation to HIV-1 susceptibility and discuss the defense
capabilities of the skin. This will establish the reasons for our investigation into these
specific skin parameters. Finally, I will discuss currently available tissue models (and
their limitations), and the overall need for a full depth, three-dimensional in vitro
organotypic foreskin model.

1.2
Human Immunodeficiency Virus Type 1 and the
Foreskin
1.2.1

HIV Introduction and Virology

HIV belongs to the genus Lentivirus, family Retroviridae, subfamily Orthoretrovirinae,
and is grouped into two types – HIV type 1 and 2 (HIV-1 and HIV-2)1,2,44. The HIV
genome consists of two identical single-stranded RNA molecules which, upon infection,
are reverse transcribed into double stranded DNA, which is in turn inserted into the
genome of susceptible host cells1,45. The genome for all retroviruses consists of three
structural genes known as gag, pol, and env, with the different HIV types varying in the
organization of these genes. The gag gene encodes proteins comprising the capsid,
nucleocapsid, and protective inner matrix that lines the host-derived membrane (p24, p7,
and p17 respectively)1,44. The pol gene encodes protease, reverse transcriptase, either
RNase H or reverse transcriptase complexed with RNase H, and integrase (p12, p51, p15,
p66 (reverse transcriptase complex), and p32 respectively)1,44. Lastly, the env gene
encodes both a surface and transmembrane glycoprotein (gp) which are known as gp120
and gp41, respectively1,44. Alongside gag, pol, and env exists a complex combination of
regulatory and accessory genes that assist in viral replication and host immune
evasion1,44. These include tat and rev, which are necessary for HIV replication initiation,
as well as nef, vif, vpr, and vpu which are important for viral replication, virus budding,
and viral pathogenesis1,44. A schematic overview of the HIV genome is provided in
Figure 1.1. While HIV-1 and HIV-2 can both infect humans, HIV-1 is the most infectious
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and most significant contributor to the global HIV pandemic2,44. For the remainder of this
thesis, the acronym HIV will be referring to HIV-1.

A

B

Figure 1.1: Structure of the HIV Virion and Genome. (A) shows the HIV virion while
(B) shows the organization of the viral genome. From Trovato et al, International Journal
of Molecular Sciences, 201846.
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Each infectious particle (as shown in Figure 1.1) consists of a viral core and outer lipid
envelope1. The viral core is conical in shape, consists of repeating units of capsid protein
(p24), and contains two identical single-stranded RNA molecules alongside the enzymes
integrase, reverse transcriptase, and protease1,44. In addition to these enzymes are the
regulatory proteins Tat, Rev, Nef, Vpu, Vpr, and Vif1,44. The viral core is surrounded by a
lipid envelope, a phospholipid bilayer that is acquired when mature viral particles bud
from an infected host cell1,44. Just below the lipid envelope is a viral protein matrix
composed of p171,44. The surface of the lipid envelope comprises host proteins and most
notably envelope (Env) glycoprotein complexes45. The Env glycoprotein complex is a
highly glycosylated heterodimer consisting of a transmembrane gp41 trimer and surface
gp120 trimer non-covalently linked to one another1,44,45. These complexes project from
the surface of the lipid envelope, with the gp120 trimer forming the extracellular domain
responsible for interacting with host target cell receptors1,44,45.

1.2.2

Virus Entry into Host Cells

The Env glycoprotein complex on surface of the HIV lipid envelope acts to facilitate
entry into susceptible host cells. The surface gp120 trimer binds with high affinity to
CD4, the primary receptor used by primate lentiviruses for attachment to host
cells1,44,45,47. CD4 binding causes a subsequent conformational change in gp120, and
exposes a co-receptor binding site1,44,45,47. One co-receptor is required to facilitate entry
into cells: these co-receptors include C-X-C chemokine receptor type 4 (CXCR4) and CC chemokine receptor type 5 (CCR5)1,44,45,47. Following binding of a co-receptor,
additional conformational changes in gp120 and subsequently gp41 trigger a membrane
fusion event between the host cell and viral envelope, depositing the viral core into the
host cell cytoplasm1,44,45,47.
HIV strains that utilizes CCR5 as a co-receptor are known as R5 tropic, and infect
primary CD4+ T cells, as well as macrophages and dendritic cells1,44,47. HIV transmitted
through use of CXCR4 as a co-receptor is known as X4 tropic, and typically infects only
CD4+ T cells1,44,47. Dual/mixed tropic viruses (known as X4R5 tropic) can infect all three
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types of cells1,44,47. HIV also exhibits a very high mutation rate, which – in untreated
individuals – can often lead to rapid evolution and development of diverse viral
quasispecies48–50. While both R5 and X4 strains appear in bodily fluids, sexual/mucosal
transmission of HIV occurs exclusively via R5 or dual tropic strains. Despite the diversity
of viral strains present in an infected partner’s genital secretion, the majority of the time
only a single strain is transmitted from an infected to a non-infected individual51–53.
Although R5 tropic virus dominates acute infection, late stage infection is often
associated with the evolution of X4 and X4R5 tropic strains which coincides with rapid
progression to AIDS1,47.
Once successful infection of a host cell has occurred, HIV can be transferred to other
immune cells in the body. This spread of HIV is believed to contribute to productive
infection, and eventual depletion of immune cells that leads to AIDS54,55. This is a
process that can occur in several ways: through (1) budding off and diffusing passively to
other susceptible cells as described previously, and (2) direct cell-to-cell transfer as
through use of either an infectious or virological synapse51.
Direct cell-to-cell transfer through an infectious synapse is a unique process that occurs
when dendritic cells are able to capture HIV-1 virions without becoming productively
infected, and transfer them intact to susceptible CD4+ T cells56,57. This process is known
as trans-infection, and occurs via formation of an adhesion molecule-based infectious
synapse between a dendritic cell and an uninfected CD4 T cell (as reviewed by
McDonald et al, 2010)58. Dendritic cells begin this process by engulfing pathogens at a
site of infection, where they mature and then migrate to local lymph nodes58. This
maturation itself is accompanied by increased antigen degradation and presentation,
shutdown of phagocytosis and macropinocytosis, and stabilization of peptide-MHC-II
(major histocompatibility complex class II) complex expression on the dendritic cell
surface58. As endocytosis is shut down, newly acquired antigens are not trafficked into
and degraded by the lyososomal degradation pathway58. Once a T cell has encountered a
dendritic cell in the lymph node, adhesion molecules such as lymphocyte functionassociated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) arrest cell
movement and allow T cell screening of the dendritic cell surface58. If the dendritic cell
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presents the correct peptide-MHC-II complexes, the T cell responds through
concentrating T cell receptors, CD4, and other molecules to form an immunological
synapse58. Intact pathogens such as HIV-1 can be transferred to T cells during this
contact, as a portion of pathogens are sequestered in invaginated membrane fold-based
structures that either traffic to the lysosome or are rerouted to the surface and excreted as
exosomes58. Sequestered HIV-1 is rapidly recruited to sites of T cell contact, viral
particles trafficked out of the HIV-1 containing cellular compartment, and into the
infectious synapse where they fuse with the uninfected T cell58.
The last HIV cell-cell transfer method occurs via formation of the virological synapse, an
adhesive supramolecular structure that acts to pass virions from an HIV infected CD4+ T
cell to an uninfected one54,59,60. When a virological synapse is being formed, Env
glycoprotein complexes displayed on the surface of infected cells bind to CD4 receptors
on uninfected cells via gp120, which forms adhesions between them (reviewed by Bracq
et al, 2018 and Ménager, M. M. & Littman, D. R., 2016)56,60. The interaction between
viral gp120 and cellular CD4 acts to recruit viral Gag protein precursors to the
intercellular surface, while also recruiting coreceptors CCR5 or CXCR4 and the adhesion
molecules LFA-1 and ICAM-156,60. Additionally, the interaction between gp120 and CD4
will trigger actin cytoskeleton remodeling and microtubule polarization towards the
developing virological synapse56,60. This allows for the formation of a stable, adhesive
junction between the two cells where assembly and budding of immature HIV virions can
occur56. These budded immature viral particles are internalized into the target cell via
endocytosis, mature within the endocytic compartment, fuse with the endosomes luminal
membrane, and are subsequently released into the cells cytoplasm56.

1.2.3

Skin Biology and Tissue HIV Infection

A key area of investigation in HIV transmission is the skin. The skin is the largest organ
of the body and acts as a complex physical barrier protecting the body from the external
environment61–63. The skin provides many critical functions, such as protection against
physical injury, ultraviolet radiation, and moisture loss, while also regulating
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temperature, synthesizing vitamin D, and acting as a sensory organ61,64,65. Importantly,
the skin acts in immunological defense of the body through providing a passive physical
barrier to microbes, producing biomolecules, and hosting immune cell sentinels63,65,66.
The skin is comprised of three major layers, the hypodermis, dermis, and the epidermis.
For the purpose of this thesis, the dermis and epidermis will be discussed.
The dermis is the layer of tissue below the epidermis, is usually >2 mm thick in most
areas of the body (extending to 4 mm thick in areas such as the back), and provides
mechanical strength and resistance to shear forces62,65,67. The dermis contains fibroblasts,
dendrocytes, macrophages, lymphocytes, mast cells, histiocytes, nerve fibres, and is
traversed by blood and lymph vessels62,65–67. The extracellular matrix of the dermis is
synthesized by fibroblasts and consists of collagen and elastic fibres, as well as
proteoglycans62,65,66. The dermis itself consists of two layers with no clear boundary
between them62,66,67. The uppermost layer is known as the papillary dermis, while the
lower portion is called the reticular dermis62,65–67. Collagen type I and III fibres are
oriented horizontally in the reticular dermal layer and provide mechanical toughness to
skin, while elastic fibres permit elastic recoil and are loosely arranged in all
directions62,67. Collagen type I comprises the bulk (80-90%) of dermal collagen, while
collagen type III makes up the rest (10-20%); despite this, other collagens such as
collagen type IV have been located here67. The papillary dermis consists of thin (mean =
38,000 nm) collagen fibres interspersed with elastic fibres, and interdigitates with the
epidermal rete ridges while the reticular dermis is composed of thick fibres of
collagen62,67. In humans, the reticular dermis is thicker than the papillary dermis as there
are large concentrations of collagen and reticular fibres localized here62,65,66.
The epidermis is the outermost layer of skin, and is a stratified squamous epithelium:
most apical is the stratum corneum, followed with the stratum lucidum, stratum
granulosum, stratum spinosum, and stratum basale62,64,66. The total thickness of the
epidermis is approximately 50 to 150 µm, although this can extend to 600 µm in the
thicker skin of the palms of the hands and soles of the feet63,67. The epidermis is
composed of keratinocytes which can produce keratin proteins62. Keratins are a family of
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30 proteins, each produced by a single gene62. These keratins form keratin intermediate
filaments that make up the internal skeleton of the keratinocytes, and as these cells
mature and differentiate, they express many different keratins dependent on the stage of
differentiation62. At the final stage of differentiation, keratinocytes contain impermeable,
tough, fibrous keratin62.
Keratinocytes are arranged in layers due to their unique lifecycle of maturation and
differentiation, as shown in Figure 1.262,68. The stratum basale of the epidermis is
composed of a single layer of continually renewing columnar basal keratinocytes, and as
these cells mature they are pushed apically which results in the formation of the stratum
spinosum62,64. Further, the keratinocytes of the stratum basale predominantly contain
keratin tonofilaments62,64. The stratum basale is also populated with melanocytes that
provide skin pigmentation, as well as immune cells like Langerhans cells and T
cells64,66,69,70. The stratum spinosum is a layer of polyhedral cells approximately four to
ten cells thick, and exists apically to the stratum basale62,64. The epithelial cells of this
layer also contain keratin tonofilaments and form multiple intercellular junctions with
one another called desmosomes, contributing to its “prickly” appearance62,64. As the cells
of the stratum spinosum further differentiate and push further outward, they form the
stratum granulosum62,64. This layer is granular in appearance, contains diamond-shaped
cells, is three to four cell layers thick, and is marked by the generation and secretion of
lipid-filled lamellar bodies and keratohyaline granules62–64,67. Lamellar bodies function to
create the skins water-impermeable barrier function of the skin, whereas keratohyaline
granules contain proteins like filaggrin which help aggregate keratin filaments in later
stages of maturation61–64. These granules also contain proteins that bind the cells of the
more apical stratum corneum together62. The stratum lucidum is the next layer of the
epidermis, and it lies between the stratum granulosum and stratum corneum62,64. This
layer is thin, comprised of very dense translucent cells, and is only present in very thick
skin such as that of the palms of the hands and soles of the feet62,66. Lastly is the most
apical layer, the stratum corneum62,64. The cells that comprise this layer are terminally
differentiated and known as corneocytes; they are large, flattened, and polyhedral in
shape, and contain cytokeratin filaments bound together by filaggrin, while the layer
itself is just 15-20 cells or 10-15 µm thick61–63,66. These cells are also dead, anuclear, and
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held together in an overlapping fashion within an organized lipid matrix61–63,66,67. These
lipids (e.g., ceramides, fatty acids, and cholesterols) are derived from the stratum
granulosum and give the stratum corneum the ability to flex and move in conjunction
with the rest of the body, while also promoting the formation of a permeability
barrier61,63,66,67. The overlapping arrangement of the cells in this layer also contributes to
the barrier function of the skin62. Additionally, the uppermost portions of the stratum
corneum are loosely organized and are shed from the skin as microscopic scales, a
process known as desquamation61–64. The total transit time of cells from the basal layer to
the stratum corneum in humans is approximately 52-75 days, with 26-42 days spent
migrating to the top of the stratum granulosum and 13-14 required to migrate to the top of
the stratum corneum62. The epidermis itself is connected to the basement membrane, an
important part of the dermoepidermal junction that connects the dermis to the
epidermis67. This basement membrane is mainly composed of laminin 332, collagen type
IV, nidogen, perlecan, heparin sulphate proteoglycans, and junctional proteins67. The
basement membrane acts as an additional mechanical barrier to the passage of pathogens,
alongside the epidermis67.
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Figure 1.2: The Layers and Composition of Human Skin. From Ramadon et al, Drug
Delivery and Translational Research, 202168.

When genital secretions containing HIV contact the foreskin, the first cells the virus will
encounter are keratinocytes. These cells are not susceptible to direct infection as they do
not express CD4, but the immune cells of the epidermis and underlying dermis are. The
epidermis contains susceptible Langerhans cells, as well as CD4+ and CD8+ T
cells66,69,70. The dermis also contains susceptible resident immune cell populations that
are susceptible (e.g., dendritic, Langerhans, and CD4+ T cells), as well as blood vessels
that enclose susceptible circulating immune cells. HIV needs to pass through the outer
epithelial layer to gain access to deeper immune cells and blood vessels. In vivo studies
utilizing rhesus macaques have revealed that HIV can cross the epithelial barrier through
physical breaks in the epithelium, and simple diffusion between the epithelial cells
themselves. Physical breaks may occur through ulceration (due to sexually transmitted
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infections), or possibly coital injury71. As shown through in vivo and ex vivo studies using
a macaque model, as well as ex vivo human studies of the female genital tract, simple
diffusion of HIV virions can occur through squamous epithelia until encountering cellular
tight junctions (Figure 1.3)72. Virions can continue to permeate the tissue via this
mechanism in areas where cell-cell junctions are absent72. These mechanisms allow for
HIV to access the deeper layers of the stratum corneum and dermal compartment, where
it can then proceed to infect susceptible immune cells.

Figure 1.3: Ex Vivo Foreskin Tissue Penetration by Labelled HIV. Inner (A) and
outer (B) foreskin tissues (foreskin anatomy found in Section 1.2.4) were
immunofluorescently imaged after being exposed to photoactivatable green fluorescent
protein Vpr-labelled HIV-1 (PA GFP-Vpr HIV-1; red) and stained for nuclei (blue).
Virions are typically found on the surface of the tissue (ES, epithelial surface) or in the
stratum corneum (SC, stratum corneum). White bar = 10 µm. From Dinh et al, PLOS
Pathogens, 201573.
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1.2.4

The Foreskin, Male Circumcision, and HIV Acquisition

The foreskin constitutes a fold of skin that covers the coronal sulcus, glans, and urethral
meatus of the non-erect penis, and is stretched back on the erect penis. While the foreskin
is one continuous sheet of skin, the portion of the foreskin that lies against the glans on
the non-erect penis is referred to as the “inner” foreskin, while that which is exposed to
air at all times is referred to as the “outer” foreskin. These two aspects are highly similar
in appearance and may differ only slightly in pigmentation. Removal of the foreskin is
termed male circumcision (MC) and removes both inner and outer aspects (Figure 1.4).

Figure 1.4: The Anatomy of the Foreskin. The non-erect penis (top) shows the inner
foreskin (red) covering the glans and coronal sulcus. This is in contrast to the outer
foreskin (green) that is always exposed. The erect penis (bottom) shows the foreskin
pulled back, exposing the coronal sulcus and glans, with both the inner and outer foreskin
aspects also exposed to external elements. Both the inner and outer aspects are removed
during circumcision, leaving the glans and coronal sulcus exposed at all times. From
Dinh et al., PLOS One, 201274.
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The foreskin is an important area known to be involved in HIV acquisition. More than 30
ecological and observational studies have suggested that HIV acquisition is reduced in
circumcised men, relative to those who are uncircumcised75,76. A meta-analysis of 27
studies showed a 68% decrease in HIV acquisition in circumcised men77. These results
and a need to discern whether they were confounded by participant behaviours (i.e.,
sexual behaviours) inspired the investigation of MC via randomized control trials
(RCTs)75. Three randomized trials were conducted, in Kenya, South Africa, and
Uganda36–38. These studies enrolled more than 10,000 heterosexual adult men overall, and
each trial concluded that there was a significant decrease, of about 50-60%, in HIV
acquisition among circumcised participants36–38,75. A further meta-analysis of these trials
highlighted they were consistent and showed little heterogeneity, despite trial variability
in terms of circumcision technique, urban vs. rural setting, age, and HIV incidence78. This
same meta-analysis highlighted that 12 months after circumcision, the protective effect of
MC was 50%, which increased to 54% at 24 months78. Additional intent-to-treat efficacy
estimates found that the trials were consistent, showing 60%, 53%, and 57% decreases in
HIV acquisition for the South African, Kenyan, and Ugandan trials respectively37,75.
Furthermore, post-trial follow-ups highlighted that the efficacy of circumcision on
hindering HIV acquisition increased over time. Three years after the Ugandan trial
closed, it was noted that circumcision was associated with a 73% decrease in HIV
acquisition79. The Kenyan trial also demonstrated increasing protective effects 42 months
post circumcision75.
This protective effect has not only been limited to HIV as these RCTs demonstrated that
heterosexual male circumcision confers protection against numerous sexually transmitted
infections. This includes human papillomavirus (HPV), herpes simplex virus type 2
(HSV-2), and genital ulcer disease (GUD)37,75. The South African trial showed urethral
HPV prevalence was significantly lower 21 months after MC compared to control men
(14.8% compared to 22.3%)75,80. This was consistent in the Ugandan trial (18.0%
compared to 27.9%), which evaluated the prevalence of HPV at the glans and coronal
sulcus at the two-year visit mark81. In the Ugandan trial, the probability of HSV-2
seroconversion over two years was 7.8% compared to 10.3% in the control arm75,81,82.
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There were, however, no differences in HSV-2 acquisition between the intervention and
control arms for the Kenyan trial83.
In addition to the protective benefits of circumcision for males, this procedure can also
reduce female partner risk for developing GUD, bacterial vaginosis (BV), or being
infected with either HPV or trichomonas infection. In the Uganda trial, female partner
HPV prevalence at year two was decreased when their male partner was circumcised,
compared to uncircumcised controls (27.8% and 38.7% respectively)82. This was
suggested to be due to both decreased acquisition and increased viral clearance in the
females84. There was also decreased GUD, trichomonas infection, and BV amongst the
female partners of circumcised men85. This decrease in BV is most likely due to
decreased total penile bacterial load and reduced pro-inflammatory anaerobic bacteria as
found in circumcised men39,86. These results suggest circumcision provides a substantial
protective benefit to both men and their female partners.

1.2.5

Hypotheses Regarding the Protective Effect of Male
Circumcision

Many hypotheses have been postulated for why MC impacts HIV susceptibility in men.
As of yet, four different mechanisms have been proposed: (1) the inner aspect of the
foreskin has a thinner keratin layer (and thus decreased barrier function) compared to the
remaining penile skin; (2) the foreskin harbours a greater density of susceptible immune
cells; (3) the immune cell populations found in the foreskin are functionally different and
more susceptible; and (4) decreased foreskin epithelial barrier integrity.
The earliest hypothesis as mentioned above was related to the thickness of the stratum
corneum of the foreskin, whereby the inner foreskin was thought to be more thinly
keratinized (cornified) compared to the skin on the shaft remaining after circumcision74.
This could allow easier passage of HIV virions through the surface of the inner foreskin
epithelium, and access to a pro-inflammatory immune milieu rich in susceptible CD4+ T
cell subsets74,87,88. In contrast, the remaining penile skin was hypothesized to harbour a
thicker cornified layer, providing a robust physical barrier to HIV virions74,89. Due to the
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difficulty in examining penile shaft skin, several groups have explored this hypothesis by
comparing the inner foreskin to the outer foreskin, taking the outer foreskin as
representative of the shaft skin remaining after circumcision. Four studies have supported
this hypothesis, with one examining cadaveric tissue, two observing but not quantifying a
thinner inner foreskin cornified layer, and the last finding a very small increase in outer
foreskin cornification90–93. However, additional quantitative studies noted either no
difference or an increased inner foreskin cornified layer thickness74,94,95. One study in
particular controlled for certain confounding variables found in other studies examining
cornified layer thickness (such as clinical indication for circumcision, or ethnic
differences in participants that can limit generalizability)74. In this study, cornified layer
thickness was examined in a blinded fashion by two independent laboratories74. Of note,
no significant differences were found in cornified layer thickness between the inner and
outer foreskin aspects or the frenar band of the healthy Ugandan men who participated in
the study74.
Secondly, it has been suggested that foreskin tissue contains a greatly increased number
of HIV susceptible immune cells relative other skin tissues. Studies of simian
immunodeficiency virus (SIV) transmission in female macaques have shown SIV infects
cells in areas of increased immune cell density below the stratum basale96. These dense
foci of immune cells additionally occur early on in infection, indicating they may be the
result of pre-existing inflammation96. Thus, it can be argued that similar increases in
foreskin immune cell density could do the same. This has been examined in several
studies looking at immune cell populations in the inner and outer aspects of the
foreskin90–92,94,97–99. Despite this, results have been inconclusive as of yet, with some
studies showing increased91,92,97,98 and some decreased90,94 inner foreskin immune cell
densities, and others no difference at all in immune cell densities between the inner and
outer foreskin99.
Third, a recent hypothesis has also suggested that HIV susceptibility in relation to the
foreskin may be due to functional differences in the immune cells residing in the tissue.
One study examined differences in immune cells between the inner and outer aspects of
the foreskin99. This study found similar densities in certain immune cells across the inner
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and outer foreskin (i.e., Langerhans and T cells), but noted that the Langerhans cells of
the inner foreskin sample their environment more frequently and are more responsive to
cytokine stimulation99. Stimulation of the inner foreskin with tumour necrosis factoralpha (TNF-α) or macrophage inflammatory protein-one alpha (MIP-1α) revealed
increased CD4+ cell recruitment to the epidermis99. Two additional studies conducted by
a different group exposed explanted foreskin tissues to HIV and found that more HIV
virions entered the inner aspect compared to the outer aspect of the foreskin91,98.
Additionally, more chemokine C-C motif ligand 5 (CCL5) was found to be released from
the epithelial cells of the inner foreskin which resulted in a greater recruitment of CD4+
cells to the epidermis of the inner foreskin91,98. This is important as CCL5 is the ligand
for the HIV-associated CCR5 receptor expressed on immune cells (e.g., monocytes,
natural killer cells, memory T cells, dendritic cells, eosinophils), and acts as a
chemoattractant for them (reviewed in Crawford et al, 2011)100. Further, this group also
observed migration of Langerhans cells, uptake of HIV by them, and subsequent
formation of contacts with CD4+ T cells in the inner aspects of the foreskin91,98. In sum,
increased activity by Langerhans cells, formation of contacts with CD4+ T cells, and
differences in epithelial cell cytokine secretion and response common in inflammation
could render the inner foreskin more susceptible to HIV.
Lastly, decreases in epithelial barrier permeability could be altering male HIV
susceptibility. In the same study mentioned as part of hypothesis three, inner foreskin
tissue cultured ex vivo with TNF-α was found to contain greater quantities of activated
Langerhans cells than that of outer foreskin tissues99. With cytokine stimulation, there
was also an influx of CD4+ T cells into the tissue epithelium, as mentioned previously99.
This could also indicate that there are differences in tissue permeability between the inner
and outer foreskin. Additionally, studies with female macaques have highlighted that
elevated inflammatory cytokine secretion in the female genital tract is associated with
proteases and negatively associated with protease inhibitors, suggesting they act to
decrease tissue barrier functionality101. Taken together, it is possible that similar cytokine
and protease production common in inflammation may influence inner foreskin
permeability and thus alter HIV susceptibility.
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An overarching theme linking hypotheses two, three, and four together is that
environmental factors may be inducing localized inflammation of the foreskin which
result in the observed changes in immune cell density, function, cytokine secretion, and
permeability. The foreskin may be influenced by the subpreputial microbiota, for
example, as examination of similar inflammation, tissue immune cell densities, and
cytokine secretion is common in vaginal microbiota-associated BV102,103. Understanding
this, it has been suggested that MC may alter the local inflammatory environment of the
foreskin by altering the composition of the penile microbiota, leading to reduced
susceptibility to HIV.
Our group has previously shown that the abundance of anaerobic bacteria in the
microbiota of uncircumcised men is correlated with HIV seroconversion; six species in
particular are correlated with increased immune cell densities in the foreskin tissues,
secretion of inflammatory cytokines, and HIV seroconversion39,41–43. Our group also
found that circumcision decreases total penile bacterial load and decreases anaerobe
prevalence39. Thus, current evidence suggests that the prevalence of certain anaerobic
species as part of the penile microbiota could lead to increased foreskin immune
activation and inflammatory responses. This in turn could be increasing the number of
HIV target cells present in the tissue, Langerhans cell sampling, and cytokine
responsiveness. As well, inflammatory cytokine-induced decreases in junction-mediated
barrier function may permit HIV virions to pass through the outer epidermis to access
tissue immune cells. This final hypothesis, however, has never been examined
mechanistically and is only posited based on observational studies.

1.3

Immune Defenses of the Skin

The skin plays a major role in protecting an individual from the external environment,
and one particular way it does so is in preventing invasion by pathogenic microbes66,104–
107

. The skin employs a variety of methods to do so, which includes physical and

immunological barriers, the commensal microbiota, as well as biomolecules and pH66,104–
107

. Lastly, Toll-like receptors (TLRs) act to sense microbial components and can activate
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different gene programs that initiate both innate and adaptive immune responses in the
host108–110.

1.3.1

Physical Barriers

The skin forms a physical barrier against the exterior environment and protects the host
through the formation of two mechanical barriers106,107,111. These two mechanical barriers
are the stratum corneum (an air-liquid interface barrier) and tight junctions of the stratum
granulosum (a liquid-liquid interface barrier)106,107,111. The stratum corneum is the
foremost physical barrier against pathogens and other external forces, and its barrier
function is based on its biochemical composition and tissue structure107,111,112, which is
often likened to “bricks and mortar”. Flattened corneocytes are surrounded by insoluble
cornified envelopes and crosslinked lipid envelopes, with lipid envelopes generated by a
monolayer of ceramides that replace the plasma membranes of the cells107. Lipid
envelopes of the cells also comprise the scaffold that extracellular lipids use to fill the
intercellular space107,111. Corneocytes are also connected to one another through
corneodesmosomes, which are modified desmosomes originating from the uppermostnucleated layers of the epidermis107,111. Corneodesmosomes are molecularly the same
compared to desmosomes in other differentiated keratinocytes but are different in that
they are immobilized at the cell periphery through enzymatic cross-linking by
transglutaminases 1, 3, and 5107,113. The layered lipid structure of the stratum corneum
provides waterproofing to the skin, and the permeability barrier as well, with the barrier
held together via corneodesmosomes107,111,114. Disruption of corneodesmosomes in
particular can cause loss of barrier function and inflammatory diseases as observed in
multiple studies involving humans and mice107,111,115–118. In one particular set of studies,
this was evident in individuals with homozygous nonsense mutations in the gene
encoding corneodesmosin, a corneodesmosome component involved in adhesive
functions107,111,118–121. This mutation leads to the extracellular portions of
corneodesmosomes being less resistant to stress, and thus are easily cleaved107,111. This is
especially present in the bottom most portion of the stratum corneum, at the interface
with the stratum granulosum107. The consequence is development of peeling skin disease,
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where mechanical separation of the stratum granulosum leaves entire areas of the skin
with no stratum corneum-based barrier function107,111. Thus, these components form an
important portion of the skin’s barrier defense, and as a whole constitute the first
protective barrier of the skin.
The tight junctions of the stratum granulosum form a second mechanical barrier against
host invasion66,106,122. Tight junctions are cell-cell junctions present in simple and
multilayered epithelia and endothelia106. Tight junctions consist of transmembrane
proteins (proteins of the claudin family, junctional adhesion molecules (JAMs), and tight
junction-associated marvel proteins like occludin) and plaque proteins (zonula occludens
(ZO) 1-3, multi-PDZ domain protein-1 (MUPP-1), cingulin)66,106. Tight junction proteins
connect to the actin cytoskeleton of neighbouring cells and act to prevent paracellular
transport of molecules in the space between cells 66,106. Only a few tight junction proteins
are unique to the stratum granulosum (i.e., occludin, cingulin)106, while others are also
present in the upper stratum spinosum (such as ZO-1, ZO-2; claudin-4, 6, 18) or all living
layers of the epidermis (claudin-1, 7; JAM-A, MUPP-1)106. The distribution and
composition of tight junction proteins is shown in Figure 1.5.
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Figure 1.5: Distribution of Tight Junction Proteins Throughout the Epidermis and
Tight Junction Composition. Cldn, Claudin; ZO, Zonula Occludens; Ocln, Occludin.
From Bäsler et al, Journal of Controlled Release, 2016106.

Experiments looking at the barrier function of tight junctions have shown they can form
an effective inside-out barrier to molecules of various sizes. Tracer molecules weighing
557 Daltons (Da), 1500 Da, 5 kilodaltons (kDa), 31 kDa, and 32 kDa can accumulate at
the tight junctions in the stratum granulosum after being injected intradermally, as well as
lanthanum3+ cations106,123–128. This has also been demonstrated through in vitro
experiments examining outside-in barrier function, where normal human epidermal
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keratinocyte (NHEK) cultures have been shown to stop apically applied tracers106,129,130.
NHEK cultures were shown to be able to exclude both ions and intermediate sized tracers
like 4 kDa fluorescein isothiocyanate (FITC) labelled dextran through action of claudin1, claudin-4, occludin, and ZO-1106,129,131. Claudin-1 and ZO-1 were also shown as
contributing to the barrier function against large tracers like 40 kDa FITC labelled
dextran106,129. Alterations in the expression or function of these components can result in
various pathologies and ultimately disrupted barrier function63,66,106,132. Numerous studies
using mice, cultured cells, and human participants have been conducted to investigate the
interactions between tight junctions and varying components of the skin barrier (reviewed
in Bäsler et al, 2016)106. A mouse study found that deletion of claudin-1 lead to death
shortly after birth due to defects in the skin barrier leading to fluid loss66,123. In a study of
patients with atopic dermatitis, it was found that at both the mRNA and protein level,
patients with atopic dermatitis had reduced expression of both claudin-1 and claudin23132. This is interesting in the sense that atopic dermatitis is a condition known for
hyperactive immune responses and dry skin (hallmarks of tight junction impairment)132.
Additional experiments in this study showed that silencing of claudin-1 expression in
primary human keratinocytes resulted in diminished tight junction function and barrier
dysfunction132. Additionally, another study showed tape stripping of mice skin (used to
remove the stratum corneum) caused downregulation of claudin-1 and 4 protein levels
(no change in mRNA expression), as well as disrupted barrier function to lanthanum3+
cations after 30 minutes133. Subsequently, an increase in claudin-4 protein expression
restored barrier function one-hour post tape stripping133. From these investigatory studies
and knockout experiments, it can be shown that tight junction proteins play an important
role in the formation of an “inside-out” barrier preventing fluid loss, as well as an
“outside-in” barrier preventing foreign substance entry.

1.3.2

The Immunological Barrier

There are several immune cells localized to the skin, and they all play an important role
in promoting and maintaining tissue function66. Dendritic cells localized and specific to
the epidermis, known as Langerhans cells, are thought to play a large role in inducing T
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cell responses to specific antigens, while recruiting peripheral immune cells through
cytokine secretion66,111,128. Langerhans cells anchor themselves to keratinocytes in the
epidermis through interacting with epithelial cell adhesion molecules or E-cadherin66. In
this, they can act to sample their environment through aiming the tips of their dendrites at
the basal portion of tight junctions or below towards the stratum basale66,111,128. Upon
Langerhans cell activation, these processes can extend upward through the tight junction
to sample the region just below the stratum corneum, or extend downward towards the
stratum basale66,111,128. Tight junctions are not broken in the former, and the epidermal
barrier is maintained: this is through the formation of a new claudin-dependent tricellular
tight junction between the dendrites of the Langerhans cell and surrounding
keratinocytes66,111,128,134. These processes allow for sampling of the environment, uptake
of external antigens by the tips of extended Langerhans cell dendrites, and immune
activation66,111. This is, however, reliant on external antigens penetrating the layers of the
stratum corneum in order to be taken up by the extended Langerhans cell
dendrites66,111,128. Langerhans cells also move from the skin towards skin draining lymph
nodes to promote tolerance in homeostasis66.
Dendritic cells reside in the dermis, known as dermal dendritic cells66. These dermal cells
can move to lymph nodes and act to promote the priming of adaptive immune responses
similar to Langerhans cells135,136. These cells are involved in maintaining homeostasis
between the host’s commensal bacteria and body, as demonstrated through studying mice
deficient in basic leucine zipper transcription factor ATF-like 3 (Batf3) necessary for
conventional dendritic cell 1 (cDC1) activation137. These mice had lower levels of CD8+
T cells specific for Staphylococcus epidermidis, a common skin bacterium, highlighting
the importance of dermal dendritic cells in maintaining control of T cells specific for
commensal bacteria137. Additionally, found in the dermal layer are macrophages, mast
cells, eosinophils, and lymphoid immune cells (reviewed in Nguyen, A.V. & Soulika,
A.M., 2019)66. Skin resident macrophages develop an immunoregulatory role, and act to
remove cellular debris; they are usually located at post capillary venules, and can act to
recruit neutrophils in the event of skin wounding66. Mast cells are involved in allergic
reactions, whereby they produce histamine66. Mast cells also produce leukotrienes that
can act to attract neutrophils to sites of inflammation, while interestingly acting to prime
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adaptive responses during cutaneous infection66. Eosinophils can produce extracellular
DNA traps in their granules, which play a role in antibacterial defense, as well as toxic
proteins and cytokines that can be used against parasitic infections66. Lastly, the dermis
contains many different lymphocytes that are important in inflammatory and homeostatic
mechanisms66. These include natural killer T cells, and most predominantly in human
skin, αβT cells66.

1.3.3

Biomolecule Defenses and pH

In defense against bacterial insult, skin cells produce antimicrobial peptides (AMPs) and
lipids138,139. AMPs are amphipathic molecules that act synergistically to disrupt microbial
membranes across a broad range of microbial species66. They can be expressed
constitutively or induced through inflammation or homeostatic changes66. AMPs are
produced as a pro-peptide and upon proteolytic cleavage, become active66. There are two
well studied families of AMPs in humans, the defensins and cathelicidins66,140,141.
Defensins are encoded by distinct genes, whereas cathelicidin is encoded by one gene66.
β-defensins differ in expression between cells, and keratinocytes of the skin constitutively
express β-defensin-1, while β-defensin-2 to 4 are expressed upon infection or injury140,142.
Cathelicidin LL-37 is also expressed differentially and can be found constitutively
expressed in neutrophils but induced by exposure to lipopolysaccharide (LPS) or vitamin
D3 in keratinocytes140,142. The pro-peptide generated from the cathelicidin gene, known
as cathelicidin antimicrobial peptide or CAMP, is proteolytically cleaved to result in a
number of mature, biologically active peptides66,140,141. The most well studied mature
peptide of this grouping is known as cathelicidin LL-3766,140,141. β-defensins and
cathelicidins then act to supplement the stratum corneum mechanical barrier by providing
an additional layer of antimicrobial defense143,144. Upon generation, they are then placed
into lamellar bodies, then localized to the stratum corneum to do so143,144. Aside from
contributing to host innate immunity, AMPs are involved in modulating host immune
responses to selectively control pathogen-induced inflammatory responses (reviewed in
Niyonsaba et al, 2006 and Pfalzgraff et al, 2018)66,139,140. Cathelicidin LL-37 in humans
has been shown to induce monocyte derived dendritic cell differentiation, cytokine
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secretion, and expression of CD8666. α- and β-defensins also act as chemoattractants for
immature dendritic cells, activated neutrophils, memory T cells, and Naïve T cells66. βdefensins 3 and 4 have also been shown to recruit monocytes and macrophages66.
Aside from AMPs, antimicrobial lipids have also been shown to exert antimicrobial
activity against specific bacterial species63,66. Molecules such as sphingomyelin and
glucosylceramides are converted into sphingosine and dihydrosphingosine that exact
antimicrobial activity against bacteria like Streptococcus pyogenes or Staphylococcus
aureus63,66.

1.3.4

The Skin Microbiota

The human skin microbiota is an incredibly important defense mechanism, acting as an
additional physical and biochemical barrier to the external environment104–106. This
barrier is established on the microbial level through (1) competitive exclusion of other
microbes, and (2) production of various antimicrobial compounds104–106. This acts to limit
the colonization of the skin by limiting the growth of possibly pathogenic
microorganisms104–106. This is best observed through studies on microbial dysbiosis and
disease development. Disturbing the skin microbiota and its homeostatic balance with the
host often leads to the development of inflammatory skin diseases, such as atopic
dermatitis or psoriasis104,106. Studies of atopic dermatitis have shown that the disease
arises due to a compromised stratum corneum 104. Additionally, copy number differences
for AMP genes like β-defensins could lead to psoriasis104. When these two important
barrier functions are reduced in the skin, it might lead to altered skin-microbiota
homeostasis through penetration of and sensitization to microbes or their components104.
Additionally, the microbiota in atopic dermatitis patients is altered in most cases of the
disease. In healthy individuals, the commensal skin microbiota is composed of bacteria
belonging to the genus Firmicutes (such as Staphylococcus epidermidis) and
Actinobacteria (such as Propionibacterium and Corynebacterium)104. In the case of
atopic dermatitis, Staphylococcus aureus colonization disrupts the microbiota and
decreases overall bacterial abundance104. Additionally, in vitro experiments examining
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the effect of commensal bacteria on the skin barrier have shown they are important for
epithelial barrier function106,145–147. Application of probiotic bacterial cell lysates to
NHEK cell monolayers can increase both tight junction protein expression and
transepithelial electrical resistance (TEER; a measure of permeability), which may
improve barrier function147. Despite this evidence, it is still unclear whether microbial
dysbiosis is causally linked to disease development, or is simply the result of abnormal
skin biology104. Thus, together with the evidence presented in Section 1.2, it is possible
that certain perturbations in the microbiota could be implicated in the development of
disease, and that this should be investigated further to establish a causal link.

1.3.5

Toll-like Receptors

Toll-like receptors (TLRs) are a class of pattern recognition receptors that sense a wide
range of microbial components and serve to protect the host by initiating innate and
adaptive immune responses (reviewed in Miller, L. S., 2008; Fore et al, 2020; Takeda, K.
and Akira, S., 2005)108–110. These microbial components are known as pathogen
associated molecular patterns (PAMPs), which are highly conserved molecular patterns
found in microorganisms108–110. TLRs exist as transmembrane glycoproteins that can
initiate intracellular signaling cascades that activate nuclear factor-kappa-light-chainenhancer of activated B cells (NF-κB) and end in the expression of immunomodulatory
genes encoding many different proteins96,133. Cytokines, chemokines, interferons, AMPs,
co-stimulatory molecules, and adhesion molecules can all be expressed upon activation of
TLRs108,110. In humans, there are 10 TLRs that differ in sub-cellular expression, as shown
in Figure 1.6. TLRs 1, 2, 4, 5, 6, and 10 are all found on the cell surface, while TLRs 3, 7,
8, and 9 are found intracellularly on the surface of endosomes108,109. TLRs located on the
external surface of cells can detect various distinct external PAMPs108–110. TLR2 can
form heterodimers with either TLR1 or TLR6 to detect triacyl and diacyl lipopeptides,
which originate from Mycoplasma and various bacteria, respectively108,110. TLR2 can also
recognize peptidoglycan common to Gram-positive and -negative bacteria, and the
TLR2/6 heterodimer can recognize lipoteichoic acid found in Gram-positive
bacteria108,110. TLR4 can recognize lipopolysaccharide from Gram-negative bacteria,
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while TLR5 can detect flagellin from flagellated bacteria108–110. Intracellular TLRs detect
components of microbes that can be found within the cell itself108–110. TLR7 and 8 can
detect uridine- or guanosine-rich single-stranded viral RNA (such as that of HIV or
influenza), while TLR9 detects hypomethylated CpG motifs in bacterial double-stranded
DNA108,110. TLR10, often found expressed on the surface of B cells, monocytes, dendritic
cells, and neutrophils, has no known PAMP that it responds to108–110. TLRs are expressed
by many cells of the skin, including keratinocytes, fibroblasts, adipocytes, Langerhans
cells, monocytes, dendritic cells, B-cells, mast cells, and monocytes105,108,109,141.
Keratinocytes are known to express TLRs 1-6, and 9 in particular96,133. By stimulating the
secretion of immune factors such as cytokines, and recruiting immune cells like
phagocytes to a site of possible infection, TLRs help in establishing and maintaining
another layer of immune defense atop of the already established barriers in this section
(reviewed in Takeda, K. & Akira, S., 2005)108–110
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Figure 1.6: Toll-like Receptor Subcellular Localization. Modified from Mogensen, T.
H., Clinical Microbiology Reviews, 2009148.
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1.4

The Microbiota and HIV-1 Susceptibility

The microbiota is a complex microbial ecosystem that rapidly colonizes its host during
and after birth104,105. The microbiota develops from exposure to environmental microbes
and becomes increasingly diverse through childhood104,105. Trillions of microbes, from
bacteria, archaea, and even viruses colonize humans, with at least 1000 different known
species of bacteria. Host factors such as genetics, sex, ethnicity, lifestyle, and diet all
influence this diverse microbial environment104,105.
The microbiota is comprised of both transient and resident microbes104. If looking at the
skin, transient microorganisms temporarily live on the skin surface, whereas resident
microorganisms are those in homeostatic balance with the host and comprise the
commensal skin microbiota104. Over decades of study, it has been determined that the
human microbiota is strongly associated with both health and the development of disease
(reviewed in Wang et al, 2017)105. Microbial dysbiosis through perturbation of the
commensal microbiota is also known to result in the development of various diseases105.
As mentioned in Section 1.2.5, a hypothesis for variable HIV susceptibility in
heterosexual men has been identified whereby penile microbial dysbiosis leads to
localized penile inflammation. A series of studies were performed to facilitate this, using
both penile coronal sulcus swabs from the RCT in Uganda as well as a cross-sectional
cohort from the RCT to examine foreskin tissues39–42. These penile swabs were taken
from uncircumcised and circumcised HIV negative men at trial enrollment, who were
then followed for the duration of the two-year trial and re-swabbed at 6 months, 1-year,
and 2-years post enrollment. Men were also monitored for HIV seroconversion.
Results from these studies showed that the odds of seroconversion increased upon
detection of multiple cytokines on the coronal sulcus surface, with detectable IL-8 and
monokine induced by interferon gamma (MIG) specifically associated with HIV
acquisition42. Further, IL-8 levels were found to decrease following circumcision42. At six
months post circumcision, IL-8 levels were significantly reduced and continued to
decline afterward42. Coronal sulcus IL-8 levels were also correlated with the density of
neutrophils and susceptible CD4+ T cell subsets (such as T helper 17 [Th17] cells) in the
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foreskin tissue42. As well, the microbiota changed significantly after circumcision. Precircumcision, the microbiota contained 38 bacterial families, was more heterogeneous,
and also was composed of several core community types40. One community type
observed was dominated by the anaerobic bacterial families Clostridiales Family XI and
Prevotellaceae, which have been identified as elevated in the human vagina during BV40.
It was found that bacterial families predominantly composed of anaerobic genera were
decreased in abundance in circumcised participants, while facultative anaerobic genera
were increased in abundance40. It was also found that there were stark differences
between the microbiota of uncircumcised and circumcised men39. Initially, men at
baseline of control (uncircumcised) and treatment (circumcised) arms showed similar
microbiota composition39. One-year post circumcision, the microbiota showed reduced
total bacterial load and biodiversity39. Specifically, 12 anaerobic taxa decreased in
prevalence and absolute abundance, with minor gains in aerobic taxa39. Lastly, it was
found that men infected by HIV had significantly higher penile anaerobe abundances at
baseline relative uninfected men41. These anaerobes included Prevotella, Dialister,
Mobiluncus, Murdochiella and Peptostreptococcus41. It was also found that
uncircumcised men with a greater absolute abundance of penile anaerobes had a greater
concentration of chemokines (such as IL-8) at the coronal sulcus41.
In sum, these results highlighted that circumcision profoundly shifts the penile
microbiota, inflammatory cytokine abundance, and HIV target cell density at the level of
the foreskin. This strongly suggests that these factors could be involved in variable male
HIV susceptibility. Anaerobic bacteria have already been known to cause BV in females
when in high abundance, and BV has been associated with vaginal inflammation and
increased risk of HIV in females102,103. As such, it is suggested that the reduction in
anaerobes may be the driving force behind circumcision’s protective effect against HIV.
From this, a plausible mechanism for HIV susceptibility can be developed involving host
immune modulation. In uncircumcised men with high anaerobe abundance, localized
secretion of chemokines like IL-8 could recruit neutrophils to the tissue. Neutrophils
would act to recruit T cells to the tissue through release of chemokines, including the
highly susceptible Th17 T cell subset. This would act to make the foreskin stochastically
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more susceptible to HIV infection by virtue of increased immune cells present in the
tissue.
Recently, a newly developed Bayesian classifier was used to extract species level data
from the two cohorts discussed previously, highlighting the impact of penile anaerobes
on local tissue inflammation and in turn, HIV susceptibility43. This study revealed that, as
can be shown in Figure 1.7, there was a strong correlation between men with a greater
proportional abundance of the anaerobe Prevotella in their microbiota and the risk of
HIV seroconversion. Total bacterial density was also significantly associated with the
risk of seroconversion, but this was not as strong of a relationship. Further, of the
anaerobic genera associated with seroconversion, six species of anaerobes
(Peptostreptococcus anaerobius, Prevotella bivia, Prevotella disiens, Dialister
propionicifaciens, Dialister micraerophilus, and Dialister succinatiphilus) were
identified and correlated with subpreputial IL-8 levels, α-defensins, the density of HIV
target cells in foreskin tissue, and seroconversion. This provides strong evidence of a
relationship between penile anaerobic species and seroconversion; however, this data
remains observational and could be confounded by anaerobe co-occurrence. Controlled
study of these anaerobic species using tissue models could provide evidence of a causal
relationship and help elucidate the exact mechanism by which they impact HIV
seroconversion. Additionally, this might guide development of novel targeted
intervention strategies to eliminate these HIV associated bacteria from the penile
microbiota.
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Figure 1.7: Microbiota Composition Stratified by Prevotella Proportional
Abundance and Relation to HIV Risk Across Uncircumcised Men in Rakai, Uganda.
(A) HIV risk increases alongside increasing Prevotella abundance and (B) total bacterial
density. C shows case/control status in the study (each black bar represents one
participant who seroconverted during the study; each grey bar a nonconverter) and
Prevotella Quartiles. (D) Proportional abundances of the bacterial genera comprising the
penile microbiota across the cohort tracked in the study (n = 188). Men were grouped via
Prevotella proportional abundance quartiles so as to use case/control status to determine
HIV risk across each quartile. PR Q, Prevotella quartile. From Prodger et al, JCI Insight,
202143.
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1.5

Current Tissue Models and Limitations

Researchers have, in the past, created in vitro co-cultures to investigate microbial-human
interactions. These in vitro models, however, quite often lacked sufficient complexity and
presented many limitations in study design, which will be discussed below.
Previous in vitro models have often consisted of peripheral blood samples or monolayers
of human cell lines inoculated with bacterial monocultures or bacterial products (e.g.,
LPS). This presents a wide variety of problems. One such problem is that cell lines or
blood samples typically do not respond to commensal bacteria as well as primary cells
isolated from tissue149,150. Monolayers also lack the complex cell-cell interactions and
overall physiology that constitutes a tissue such as skin, while also impeding the addition
of other cell types necessary to mimic the tissue (e.g., fibroblasts, melanocytes, immune
cells)151. Submerged monolayers or blood cell suspensions also do not provide a
physiologically relevant, dry surface for inoculation with a microbiota. One way to solve
this limitation is through culturing a piece of surgically removed foreskin tissue, known
as an explant. This strategy is also limited, however, as tissue viability and structure is
gradually lost in culture due to cell migration152. This is problematic, as it is necessary to
have a tissue remain stable over time to successfully study microbiota-tissue interactions.
Finally, bacterial cell lysates applied to such models ignore skin-microbiota interactions,
which are known to be imperative to skin barrier functioning and host processes
(established in Sections 1.3.4 and 1.4)153.

1.6
The Need for a Three-Dimensional, In Vitro
Organotypic Foreskin Model
The studies relating the penile microbiota to HIV acquisition have thus far all been in
vivo observational studies, limiting our ability to establish causality or explore the
mechanics and relationship between the two. Additionally, anaerobes associated with
HIV acquisition co-occur in the microbiota, limiting the ability to elucidate which
specific species drive HIV susceptibility, or target species for intervention development.
In order to empirically determine if and how the penile microbiota modulates the host
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immune system and increases HIV susceptibility, it is necessary to generate an in vitro
organotypic foreskin equivalent from primary skin cells. This foreskin model would
bypass limitations imposed by previous work investigating tissue-microbiota interactions
presented in Section 1.5. First, the skin model posited is a three-dimensional tissue that
allows for complex interactions between the dermis, epidermis, and the cells that
compose each of these. As the skin model is further refined and developed, additional cell
types (e.g., melanocytes) and immune cells could be added to the tissue in a layer specific
fashion, in sharp contrast to monolayers that do not permit this. Specifically, the dermal
portion of the tissue mimic would provide an area for adding CD4+ T cells. The tissue
model also presents a physiologically relevant dry surface for the culture of penile
bacteria, in comparison to submerged monolayers that do not provide this. Additionally,
primary cells that constitute the tissue would likely more accurately respond to
commensal bacteria added to the top of the epidermal tissue surface149,150. Lastly, this
model could present a more stable alternative to conventional explant cultures commonly
used in HIV infection studies. Our group and others have observed that explant cultures
deteriorate over time during culture, with the epithelium sloughing off and the dermis
losing shape. Being able to develop a three-dimensional tissue mimic, as is the basis of
this project, could remedy this problem in that the organotypic tissue may act to better
maintain the physical epithelial barrier over time in addition to the previously mentioned
benefits. This would permit the study of penile anaerobes selectively using a tissue that
closely mimics in vivo foreskin tissue, without the caveats faced by current tissue models
and explanted tissue itself.

1.7

Hypothesis and Specific Aims

Based on the lack of in vitro tissue models needed to study anaerobe-induced
inflammation, I hypothesized that an in vitro, organotypic, 3D foreskin model could be
developed and be able to model in vivo foreskin in structure and function. Specifically, I
hypothesized that this organotypic tissue model would be able to mimic the skin in
structure by generating a multilayer epithelium comprised of differentiated cells. It would
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also retain relevant functional characteristics, including the ability to sense and respond
to microbial products like LPS, while providing a mechanical barrier.

1.7.1

Specific Aims

Aim 1: Develop the 3D, in vitro organotypic foreskin model and characterize its structure
relative fresh and seven-day explant-cultured foreskin tissues.
Aim 2: Characterize gene expression for microbial sensors, antimicrobial peptides, and
the ability to secrete cytokines in response to bacterial ligand application by the
organotypic foreskin model, relative fresh and explant cultured tissue.
Aim 3: Assess the barrier function of the organotypic model in comparison to fresh and
seven-day explant-cultured foreskin tissues.
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Chapter 2

2

Participants and Methodology
2.1

Participants

Two participant populations were enrolled in this study. One population consisted of
adult men (≥18 years of age) undergoing circumcision for elective reasons (e.g.,
religious, cultural, or cosmetic) at the University Urology Associates (UUA) in Toronto,
Ontario. Exclusion criteria included clinically apparent genital infection, recent antibiotic
use (>30 days), and current hormone therapy. The second population consisted of boys
(<18 years of age) undergoing circumcision at the London Health Sciences Centre
(LHSC), London, Ontario, for either elective or medically indicated reasons (e.g.,
treatment of recurrent balanitis, phimosis, recurrent urinary tract infection [UTI], or
balanitis xerotica obliterans [BXO]). Both adult and paediatric participants were excluded
from the study if they displayed medical contraindications to circumcision surgery. Adult
participants completed a behavioural questionnaire before surgery/sample collection.
Paediatric participants or their substitute decision maker (SDM) completed a brief
questionnaire regarding signs or history of genital infection and/or antibiotic use. All
adult participants provided written consent; paediatric participants provided consent
themselves if >16 years and assent if aged 8-16; and SDM of paediatric participants <16
years provided written consent. Formal ethics approval was obtained from institutional
review boards (IRB) at the University of Toronto and the University of Western Ontario
(protocol IDs 113008 and 111054, Western; Appendix A).

2.2

Sample Collection

Foreskin tissue was placed into a sterile 50 mL conical tube in the operating room and
transported back to Western university within 4 hours of surgery. Segments of the
harvested tissue were processed and stored in several ways, depending on requirements
for future analysis, as schematically depicted in Figure 2.1, and described below.
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Tissues were sectioned for immediate use in primary cell isolation (Section 2.3) and/or
explant assays, cryopreserved for immunofluorescence microscopy (IF), or quantitative
polymerase chain reaction (qPCR). For IF, two 3 x 3 mm sections of inner and outer
foreskin tissue were placed in cryomolds, embedded in Tissue-Plus optimal cutting
temperature embedding medium (OCT; Thermo Fisher Scientific) and were snap-frozen
at -80°C. For qPCR, an eight-millimeter tissue biopsy punch (Integra Militex) was used
to obtain a section that was placed into RNAlater (Invitrogen) at 4°C overnight and then
frozen at -80°C. When RNAlater was not available, the qPCR punch biopsy was
cryopreserved in a mixture of 90% heat-inactivated fetal bovine serum (HI FBS; Gibco)
and 10% DMSO (dimethyl sulfoxide; MilliporeSigma) by placing in a Nalgene Mr.
Frosty freezing unit (Thermo Fisher Scientific) overnight at -80 prior to long-term storage
in liquid nitrogen. Samples frozen using this method were then placed into RNAlaterICE (Invitrogen) and allowed to thaw at -20°C to preserve RNA quality when used for
qPCR analysis. For culture of tissue explants, tissue samples were divided into 16
additional sections using an eight-millimeter tissue biopsy punch. Eight sections were
cultured in Maintenance Medium (Table 2.8) for seven days prior to further assays
(“seven-day explants”). The remaining eight pieces were taken as representative of fresh
in vivo tissue. For both the freshly analyzed and seven-day explant tissues, four sections
were subject to a permeability assay (below) and the other four subject to a Toll-like
Receptor stimulation assay (below).
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Figure 2.1: Summary of Foreskin Tissue Processing. Donor tissues receive varying
treatment to generate organotypic, explant cultured, and frozen tissues for use in future
analysis. Donor tissues first have two pieces of inner and outer foreskin excised using
scissors (bottom), which are immediately frozen in OCT medium. The remaining
foreskin tissues are trimmed of any remaining blood vessels. A portion of this tissue is
then used for cell extraction (top) to generate organotypic foreskin tissues. The remaining
tissue is then cut using a biopsy punch with two pieces placed into RNAlater and stored
at -80°C for qPCR analysis, with remaining punch biopsies used for explant culture
generation. Figure created with BioRender.com.

2.3
Isolation and Culture of Epidermal Keratinocytes
and Dermal Fibroblasts
Tissues were processed according to the protocol established by Gangatirkar et al,
2007154. In brief, foreskin tissue samples were washed with 1X Dulbecco’s phosphate
buffered saline (DPBS; Gibco), with blood vessels removed thereafter. Tissues were then
sectioned into pieces approximately 0.5 cm x 0.5 cm, covered in a 2.4 U/mL Dispase II
solution (Gibco) at 4°C overnight followed with one hour at 37°C the next day to
facilitate separation of the dermis from the epidermis. The dermis and epidermis were
mechanically separated with forceps.
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To isolate fibroblasts, dermal sections were placed into Dispase and collagenase
(dissolved in 1X DPBS; 2.4 U/mL Dispase II, 780 U/mL collagenase type IV;
collagenase from Gibco) and minced into smaller pieces with scissors. Minced dermal
tissues were incubated in a 37°C, 5% CO2 humidified incubator for two hours, with brief
vortexing of the samples every 30 minutes. The resulting dermal suspension was diluted
with three volume equivalents of DMEM Complete medium [Dulbecco’s modified eagle
medium (DMEM; Gibco) supplemented with 10% HI FBS (Gibco) and 1% penicillinstreptomycin (P/S; MilliporeSigma)], then filtered through a 70 µm cell strainer. The
fibroblast suspension was then centrifuged at 114 x g for eight minutes, resuspended in
DMEM Complete, and the number of Trypan Blue-excluding cells was determined (0.4%
Trypan Blue; Gibco). Live cells were then plated at a density of 5.3 x 104 cells/cm2.
To isolate keratinocytes, epidermal sheets were placed into a solution of 0.05% trypsinethylenediaminetetraacetic acid (EDTA; Gibco), minced with scissors, and left in a 37°C,
5% CO2 humidified incubator for seven minutes. The resultant epidermal cell suspension
was neutralized by adding two volume equivalents of a solution comprised of 20% HI
FBS in 1X DPBS, then filtered through a 70 µm cell strainer. The keratinocyte
suspension was then centrifuged at 114 x g for eight minutes and resuspended in
keratinocyte serum-free medium (K-SFM) supplemented with 894 µL bovine pituitary
extract (BPE), 2.8 µL recombinant epithelial growth factor (rEGF), and 2% Primocin
(BPE and rEGF from Gibco, Primocin from InvivoGen; medium henceforth known as KSFM Complete). These cells were then counted via Trypan Blue exclusion and plated at a
density of 5.3 x 104 cells/cm2.
Fibroblasts were maintained in DMEM Complete with medium changed every other day
and passaged when 80-85% confluent. Fibroblasts were subcultured by rinsing cells with
1X DPBS, using a solution of 0.05% Trypsin-EDTA to dissociate cells from their cell
culture vessel, neutralizing with DMEM Complete, centrifuging at 114 x g, resuspending,
and replating at a ratio of 1:10. Fibroblasts were cryopreserved after proliferation (often
at passage 4) by pelleting dissociated cells at 114 x g for 7 minutes, resuspending in cell
freezing mixture (50% HI FBS, 40% DMEM Complete, and 10% DMSO), placing into a
cell freezing unit, and freezing at -80°C.
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Keratinocytes were allowed to reach 80-85% confluence, then subcultured routinely.
Cells were maintained in K-SFM Complete with medium changed every other day and
passaged when 80-85% confluent. Passages were accomplished by incubating cells with
0.5 mM EDTA in 1X DPBS, then incubating with Accutase (MilliporeSigma) to
dissociate cells from their cell culture vessel, neutralizing with 20% HI FBS in 1X DPBS,
centrifuging at 114 x g to remove serum, resuspending, and replating at a ratio of 1:2.
Cells were monitored via microscopy using a ZEISS Axio Observer.A1 inverted
microscope.

2.4

Immortalization of Foreskin Keratinocytes

Primary human keratinocytes undergo cellular senescence after approximately 10
doublings. To maximize keratinocyte longevity for this project, it was necessary to
immortalize these cells. To do this, primary keratinocytes were transduced with a
replication-incompetent amphoteric retroviral vector encoding HPV16 E6 and E7
oncogenes, as well as a resistance gene for the antibiotic neomycin. These oncogenes,
when successfully transduced into keratinocytes, extend the lifespan of the cell through
production of E6 and E7 oncoproteins.
PA317 LXSN virus packaging cells were purchased to produce this retroviral vector
(American Type Culture Collection [ATCC] CRL-2202). These cells contained the
pLXSN16E6E7 insert, and when cultured, produce a retroviral vector which can be
harvested from supernatant. To transduce keratinocytes, keratinocytes were washed with
1X DPBS, and a small volume (e.g., 1 mL per T25, 3 mL per T75) of transduction
cocktail was added to the culture vessel (transduction cocktail contents found in Table
2.1). After six hours, additional K-SFM Complete was added to the cell culture vessel
such that the amount of medium within the vessel was at the required level for typical cell
culture (e.g., 9 mL medium needed for a T75, total volume with cocktail is 12 mL). 24
hours following the addition of the transduction cocktail, cell culture medium was
replaced. 48 hours post transduction cocktail addition, K-SFM supplemented with
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Geneticin (Gibco; a structural analog of neomycin; final concentration 50 µg/mL in
medium), was added to the cell culture vessel to select for transduced cells. Transduced
primary keratinocytes were then subcultured routinely as described in Section 2.3, but
now grown only in K-SFM supplemented with the selection agent Geneticin as opposed
to Primocin.

Table 2.1: Transduction Cocktail Recipe.
Reagent
Protamine Sulphate (1 µg/mL)
K-SFM Complete
PA317 Packaging Cell Supernatant
Total Volume

Volume (µL)
20
1800
200
2,000 µL

Transduced keratinocytes were harvested and snap frozen after completing selection in
Geneticin supplemented media and compared to (if available) matched non-transduced
keratinocytes immediately snap frozen before the immortalization procedure.
Keratinocytes were thawed, and genomic DNA isolated using a DNeasy Blood and
Tissue Kit (Qiagen) following the manufacturer’s spin column protocol. Samples were
analyzed spectrophotometrically for concentration and purity, then subject to polymerase
chain reaction (PCR) amplification. PCR was performed using a SimpliAmp Thermal
Cycler (Applied Biosystems) with the reaction components listed in Table 2.2, primers in
Table 2.3 and reaction conditions in Table 2.4. PCR amplicons were then subject to gel
electrophoresis for visualization of the HPV16 E6E7 amplicon. When available,
comparison between non-transduced and transduced keratinocytes from the same patient
was conducted. Amplicons were resolved by electrophoresis in a 1% Tris-acetate-EDTA
(TAE) agarose gel stained with RedSafe (FroggaBio) for 45 minutes next to a 1 kilobase
(Kb) Ready-to-use DNA ladder (Simply Biologics) and visualized using a Gel Doc EZ
imager system with Image Lab 4.0.1 software (both from Bio-Rad Laboratories).
Successfully transduced keratinocytes were cryopreserved after proliferation (often at
passage 6). Dissociated cells were pelleted at 114 x g for 7 minutes, resuspended in cell
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freezing mixture (80% K-SFM Complete, 10% HI FBS, and 10% DMSO), placed into a
cell freezing unit, and frozen at -80°C.

Table 2.2: Transduction Verification PCR Reaction Components.
Component
2X KAPA HiFi HotStart Ready Mix (Kapa
Biosystems)
Forward Primer (1 µM)
Reverse Primer (1 µM)
Keratinocyte Genomic DNA
Total Volume

Volume (µL)
13
5
5
2
25 µL

Table 2.3: Primers used for Transduction Verification PCR. The primer pair was
obtained from Choi et al, 2017155
Primer sequences

Gene of
Interest
HPV16
E6E7

Forward (5′ -3′)
CTAGCTAGCATGCACCAAAAGAGA
ACTGC

Reverse (5′-3′)
CCGGAATTCTTATGATGGTTTCTGA
GAACAGATGGG

Table 2.4: Transduction Verification PCR Conditions.
Step
Initial Denaturation
1. Denaturation
2. Anneal
3. Extend
Final Extension
Storage

2.5

Thermocycler
Temperature (°C)
95
95
60
72
72
4

Time

Number of Cycles

3 min
30 s
30 s
1 min
5 min
∞

1
35
1
-

Casting Organotypic Foreskin Models

Organotypic foreskins were prepared as described in the protocol established by
Gangatirkar et al, 2007, with some modifications154. A summary of modifications is
shown in Table 2.5, with the entire casting process shown below in Figure 2.2. For
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development and testing of the in vitro organotypic foreskin model, keratinocytes
between passage 10 and 14 were most routinely used, while fibroblasts between passage
4 and 25 were used. Each was used to cast organotypic foreskins one to two passages
after thawing.

Table 2.5: Modifications to Organotypic Foreskin Development Protocol.
Change Number

Original Protocol (Gangatirkar
et al, 2007)

New Method

1

Use cellular layer cell suspension
concentration of 2.3 x 105
cells/mL when casting the
collagen cellular layer.

Increase cellular layer cell suspension
concentration to 3.28 x 105 cells/mL.

2

Immediately culture keratinocyteseeded collagen in
Epidermalization Medium.

Grow keratinocyte-seeded collagen for
10 days in K-SFM Complete medium,
prior to the one week of culture in
Epidermalization Medium.

3

4

Seed 30 µL of keratinocytes at
1.667 x 106 cells/mL onto the
collagen surface.
Add the 30 µL keratinocyte
suspension as a single droplet to
the center of the collagen
hydrogel.

Seed 50 µL of keratinocytes at 16.67 x
106 cells/mL onto the collagen surface.
Add the 50 µL droplet of keratinocytes as
individual 10 µL droplets evenly across
the surface of the collagen, rather than
directly in the center.

Figure 2.2: Overview of Methods used for Development of a 3D In Vitro,
Organotypic Foreskin Model. Figure created with BioRender.com.
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To create a dermal equivalent, acellular and cellular collagen layers were prepared and
cast into 6-well plate Transwells (Corning). The 6-well Transwell membrane was
composed of transparent polyethylene terephthalate and had a pore size of 3.0 µm. To
prepare the initial acellular layer of collagen, pre-mix solution (Table 2.6) was added to
bovine type 1 atelocollagen (Nutragen) and DMEM Complete as per the ratio established
in Table 2.6 (next to “Acellular Collagen Layer”), all prepared and kept on ice. 1 mL of
this mixture was cast into the apical chamber of 6-well Transwell inserts and allowed to
polymerize for 30 minutes in a 37°C, 5% CO2 humidified incubator. During this process,
isolated primary foreskin fibroblasts were washed once with 1X DPBS, incubated for five
minutes with 0.05% Trypsin-EDTA in a 37°C, 5% CO2 humidified incubator, neutralized
with DMEM Complete, centrifuged, resuspended, and counted via Trypan Blue
exclusion. To prepare the cellular layer of collagen, a 3.28 x 105 cells/mL dilution was
created and added to a combination of pre-mix and type 1 bovine atelocollagen as shown
in Table 2.6, all on ice. 3 mL of this mixture was carefully added on the top of each
polymerized acellular collagen layer and allowed to polymerize for two hours in a 37°C,
5% CO2 humidified incubator. After polymerization of the cellular collagen layer, the
Transwell inserts were placed into deep 6-well plates (Corning), and 15 mL of Cast Feed
Medium (recipe as shown in Table 2.7) was added to the basal chamber of each well. The
dermal equivalents were then kept in a 37°C, 5% CO2 humidified incubator. 24 hours
after casting the dermal equivalents, 3 mL of Cast Feed Medium was added to the apical
Transwell compartment, with the dermal equivalents returned to the incubator for six
further days of culture. Cast feed Medium was replaced every other day during this
process.
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Table 2.6: Organotypic Foreskin Casting Recipes. Reagent preparation is as described
in Gangatirkar et al, 2007.
Recipe for:

Reagent

1 Well

Volume (µL)
3 Wells
1185
117
15
360
1320
2,997 µL

6 Wells
2400
234
30
730
2600
5,994 µL

5X DMEM
L-Glutamine
Primocin
NaHCO3
HI FBS
Total Volume

395
39
5
120
440

Acellular
Collagen Layer

Pre-Mix
DMEM Complete
Collagen
Total Volume

180 µL
320 µL
500 µL
1 mL

540 µL
960 µL
1,500 µL
3 mL

1,080 µL
1,920 µL
3,000 µL
6 mL

555 µL

1,665 µL

3,330 µL

Cellular Collagen
Layer

Pre-Mix
Fibroblast Cell
Suspension (3.28 x
105 cells/mL)
Collagen
Total Volume

945 µL

2,835 µL

5,670 µL

1,500 µL
3 mL

4,500 µL
9 mL

9,000 µL
18 mL

Pre-mix

999 µL

Table 2.7: Cast Feed Medium Recipe. Reagent preparation is as described in
Gangatirkar et al, 2007. Final solution is then filter sterilized using a 0.2 µm filter.
Reagent
5X DMEM
L-glutamine
NaHCO3
Gentamicin or Primocin (optional)
HI FBS
dH2O
Total Volume

Volume (mL)
100
10
13
0.5
50
340
500 mL

After a total of seven days culturing the dermal equivalent, immortalized primary
foreskin keratinocytes were added apically to the dermal equivalent. Keratinocytes were
incubated with 0.5 mM EDTA for five minutes, then incubated with Accutase enzyme for
14 minutes. The Accutase enzyme was diluted with a solution of 20% HI FBS in 1X
DPBS, cells were counted via Trypan Blue exclusion, centrifuged at 114 x g for eight
minutes, and then plated on top of the collagen layer as a 50 µL volume of concentrated
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cells (1.67 x 107 cells/mL). This volume was dispersed evenly across the collagen gel
surface, as five individual 10 µL droplets. Immediately after this, the collagen hydrogel
was left undisturbed in a sterile tissue culture laminar flow cabinet for five minutes, then
moved to a 37°C, 5% CO2 humidified incubator for one hour to facilitate keratinocyte
attachment to the collagen gel. After one hour of incubation, K-SFM Complete was
added to the apical and basal chambers of Transwells and cultures incubated for 10 days
in a 37°C, 5% CO2 humidified incubator with medium changes every other day.
Following the 10-day incubation in K-SFM Complete, keratinocytes were viewed on the
surface of the collagen layer using phase-contrast microscopy and assessed for
confluence. If cells were not observed as a 100% confluent monolayer, they were
incubated further and observed each day for confluence. At 100% confluence, K-SFM
Complete was removed from the apical and basal Transwell aspects. 9 mL of
Epidermalization Medium (recipe shown in Table 2.8) was then added to the basal
compartment such that the medium touches the Transwell base without air-bubbles
between the two. The apical aspect was left uncovered with culture medium, such that it
was exposed to air continually and allowed to dry (or become “air-interfaced”). The airinterfacing procedure, in combination with switching to medium containing a higher
concentration of calcium, allows the monolayer of keratinocytes to begin differentiation
and stratification on the collagen gel154. These organotypic constructs were cultured for
seven days with medium changes every other day in a 37°C, 5% CO2 humidified
incubator. All organotypic foreskins were mechanically agitated at room temperature
outside of an incubator for 15 minutes every other day during this culture period using a
Belly Button Shaker (IbI Scientific) at half power unless otherwise indicated. Mechanical
agitation was used to simulate shear forces experienced by in vivo tissue.
Following the seven-day culture period in Epidermalization Medium, organotypic tissues
were then incubated with Cornification Medium (recipe shown in Table 2.8) added to the
basal Transwell aspect in place of Epidermalization Medium. Skin cultures were then
cultured for seven days in a 37°C, 5% CO2 humidified incubator with cornification
medium changes every other day.
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Lastly, following the seven-day incubation in Cornification Medium, organotypic
cultures were then incubated with Maintenance Medium (recipe shown in Table 2.8)
added to the basal Transwell aspect in place of Cornification Medium. Skin cultures were
cultured for seven days in a 37°C, 5% CO2 humidified incubator with medium changes
every other day. At the completion of this incubation period, skin cultures had fully
matured and were ready for further experimentation.

Table 2.8: Organotypic Foreskin Developmental Medium Recipes. Reagent
preparation is as described in Gangatirkar et al, 2007. Final solution pH is adjusted to
between 7.0 and 7.2 and is then filter sterilized using a 0.2 µm filter.
Reagent
5X DMEM
NaHCO3 Solution
5X Hams F12
L-Glutamine
Hydrocortisone
ITT
EOP
Adenine
Selenium
Gentamicin or Primocin
(optional)
CaCl2
HI FBS
Progesterone
dH2O
Total Volume

2.6

Volume (mL)
Cornification
Medium

Epidermalization
Medium

Maintenance
Medium

75
9.75
25
10
0.4
1
1
1
1

50
6.5
50
10
0.4
1
1
1
1

50
6.5
50
10
0.4
1
1
1
1

0.5

0.5

0.5

1
1.5
1
380

1
10
380

1
5
380
500 mL

Fresh Tissue and Explant Culture

Fresh tissue and explants were prepared by taking sections from foreskin tissue within
four hours after circumcision surgery, after washing of the tissue with 1X DPBS and
removal of visible blood vessels. Sections were cut evenly using an 8 mm tissue biopsy
punch (Integra Militex) and placed onto the apical surface of SPONGOSTAN dental
sponges (cut into thirds, one third per 24-well plate well; from Ethicon) or 24-well
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Transwells (Corning). The 24-well Transwell membrane was composed of transparent
polyethylene terephthalate and had a pore size of 0.4 µm. 600 µL of Maintenance
Medium was added to each well of a 24-well plate with either a dental sponge or a
Transwell insert. Medium was added such that the dental sponge was saturated with
medium without submerging the tissue, or the Transwell membrane was in contact with
basal chamber medium. Explants were either used in assays immediately (in Transwell
inserts, as representative of in vivo state) or cultured for seven days on a dental sponge in
a 37°C, 5% CO2 humidified incubator, with medium changes every other day. At the end
of the seven-day culture period, tissue explants were placed into 24-well Transwell
inserts for further experimentation.

2.7
Tissue Sectioning and Immunofluorescence
Microscopy
Organotypic foreskin cultures, but not fresh or explant-cultured tissues, were fixed
overnight in 4% formaldehyde in piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES)
Buffer, washed with 1X DPBS, and gradually dehydrated in a sucrose gradient (sucrose
changed every other day; solutions used: 10%, 20%, 30%, and lastly a half-half mix of
30% sucrose and OCT medium). Organotypic foreskin tissues were again washed briefly
with 1X DPBS to remove any remaining sucrose and blotted using Kimwipes (Kimtech
Science) to dry the exterior surface. Organotypic and explant tissues were placed into
OCT medium, frozen on dry ice, and stored at -80°C until processed for
immunofluorescence microscopy.
Tissue blocks of organotypic, fresh, seven-day explant, and immediately frozen tissues
were sectioned at -20°C using a Leica CM350 cryostat to a thickness of 10 µm and
placed on Fisherbrand Colorfrost Plus microscope slides. Each block was sectioned to
yield two slices per microscope slide. Regions just outside the tissue sections were circled
with a hydrophobic PAP pen (Electron Microscopy Sciences). The tissue sections were
then fixed using 200 µL of freshly made 3.7% formaldehyde in PIPES buffer for 10
minutes (PIPES Buffer recipe in Table 2.9). Tissue sections were then washed by dipping
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slides three times sequentially in three Coplin staining jars filled with 1X DPBS, then
blocked for 30 minutes using 100 µL Blocking Solution (recipe as per Table 2.10).

Table 2.9: PIPES Buffer Recipe. Combine MgCl2, ethylene glycol-bis(β-aminoethyl
ether)-N,N,N′,N′-tetraacetic acid (EGTA), and PIPES in a beaker with 500 mL of H2O,
and pH to 6.8 using NaOH. Following this, add H2O to the solution such that the final
volume is 630 mL. Solution is then filter sterilized after preparation using a 0.2 µm filter.
Reagent
0.9M MgCl2
0.25M EGTA
PIPES
dH2O

Volume/Mass
2.2 mL
4 mL
30.2 g
X mL

Total Volume

630 mL

Table 2.10: Blocking Solution Recipe. Solution is then filter sterilized after preparation
using a 0.2 µm filter.
Reagent
Normal Donkey Serum (JIR)
Triton X-100 (Sigma Aldrich)
NaN3 (Sigma Aldrich)
1X DPBS (VWR)
Total Volume

Volume
50 mL
500 µL
500 µL
449 µL
51.449 mL

Following this, tissue sections were incubated with 100 µL of mouse anti-human primary
antibody for E-cadherin (1:50 in Blocking Solution) for one hour at 37°C (antibodies and
dilutions in Table 2.11). Tissues were immediately washed after incubation, with 100 µL
of donkey anti-mouse Alexa Fluor 647 (AF647) secondary antibody (1:400 in Blocking
Solution) added to the tissue surface after and incubated for 30 minutes at room
temperature. After this, tissues were washed in 1X DPBS, had 100 µL of rabbit antihuman primary antibody for claudin-1 (1:200 in Blocking Solution) added to their
surface, and incubated for another hour at 37°C. This was followed with another wash,
and subsequent incubation using donkey anti-rabbit AF546 secondary antibody (1:400 in
Blocking Solution) following the steps before. Tissues were then stained for filaggrin by
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incubating for one hour at 37°C with 100 µL of mouse anti-human AF488 primary
antibody (1:50 in Blocking Solution). Following antibody incubations, 60 µL of DAPIFluoromount-G (Invitrogen) was added to the surface of the tissue sections. A cover slip
was then placed on top of the microscope slide, and the cover slip edges sealed with clear
nail polish. Slides were stored at 4°C until ready to be imaged with a Leica DM5500B
fluorescence microscope equipped with CFP, GFP, DsR, and Y5 filter cubes.

Table 2.11: Antibodies used for Immunofluorescence Staining.
Target
Human
claudin-1
Human
E-cadherin
Human
filaggrin
Rabbit
IgG*
Mouse
IgG*

Type

Clone

a

Poly

1°

Mono

1°

Mono

b

Poly
Poly

1°

2°

2°

Host
Species

Dilution
Factor

Fluorophore

Rabbit

1:200

None

Mouse

1:50

None

Mouse

1:50

Invitrogen

Donkey

1:400

Invitrogen

Donkey

1:400

Supplier
Abcam
BD
Biosciences
Santa Cruz
Biotechnology

Alexa Fluor
488
Alexa Fluor
546
Alexa Fluor
647

Catalog and
Lot Number
Cat: ab15098
Lot:
GR3248184-1
Cat: 610181
Lot: 7187865
Cat: SC-66192
Lot: H2019
Cat: A10040
Lot: 1946340
Cat: A31571
Lot: 2045337

*Binds both heavy and light IgG chains (H + L)

2.8
Toll-like Receptor, Tight Junction, and Defensin
Gene Expression Analysis
Toll-like receptor, tight junction, and β-defensin mRNA levels were quantified between
organotypic, explant cultured, and immediately frozen tissue. RNA extraction and
purification were performed using an Aurum Total RNA Fatty and Fibrous Tissues Kit
(Bio-Rad Laboratories). Tissues were placed into 1 mL of PureZOL, briefly minced with
scissors, then homogenized on ice using a Fisher Scientific Model 100 Sonic

a

Primary

b

Secondary
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Dismembrator in short five-second pulses on power setting four. The Aurum Total RNA
Fatty and Fibrous Tissues Kit spin protocol was followed for RNA isolation. RNA
concentration and purity were measured using a Nanodrop 2000c Spectrophotometer
(Thermo Scientific).
cDNA was synthesized on a SimpliAmp Thermal Cycler (Applied Biosystems) from the
previously extracted and purified RNA using an iScript cDNA Synthesis Kit (Bio-Rad
Laboratories) following the manufacturer’s protocol. Following this, cDNA was either
stored at -20°C for later use, or immediately used for qPCR. cDNA was diluted to a
concentration of 13.33 ng/µL (based on the starting amount of RNA in the reverse
transcription step) in ultrapure water for use in the qPCR reactions. qPCR reactions
included 20 ng of cDNA with the components listed in Table 2.12 and were performed on
a QuantStudio 5 Real Time PCR System (Applied Biosystems). Primers and their
optimized concentrations are listed in Table 2.13, while qPCR conditions are shown in
Table 2.14. Copy numbers of target mRNA were determined through absolute
quantitation using a seven-point standard curve and normalized in relation to
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA copy numbers. Double
stranded standards used in the qPCR reactions are shown in Table 2.15. gBlocks Gene
Fragment (Integrated DNA Technologies) standards were generated in silico. After
analyzing primer binding sites, a region incorporating the primer binding sites (near the
center of the standard) as well as part of the surrounding mRNA sequence was selected
for standard generation such that final standard length was approximately 300-350 base
pairs (bp).

Table 2.12: qPCR Reaction Components for Gene Expression Analysis.
Component
cDNA Template
SYBR Green PCR Master Mix (Applied
Biosystems)
Forward Primer
Reverse Primer
dH2O (DNase and RNase free)
Total Volume

Volume (µL)
1.5
7.5
0.75
0.75
4.5
15 µL
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Table 2.13: Primer Sequences used for Gene Expression Analysis. Toll-like receptor
primer sequences were obtained from Fitzner et al, 2008, while GAPDH primer
sequences were obtained from Stupp et al, 2005156,157. Primer sequences for claudin-1
and β-defensin-1 were kindly provided by Luana Langlois (Laboratory of Dr. Gregor
Reid), Western University. Source publications for these primers, in order, are as follows:
Akizuki et al, 2018; Klag et al, 2018158,159.
Target of
Interest

Primer Sequences

Primer
Concentration (µM)
Forward Reverse

Accession
Number

Forward (5′-3′)

Reverse (5′-3′)

TLR 1

CAGTGTCTGGT
ACACGCATGGT

TTTCAAAAACC
GTGTCTGTTAAG
AGA

8

8

NM_003263

TLR 2

GGCCAGCAAAT
TACCTGTGTG

AGGCGGACATC
CTGAACC

16

16

NM_003264

Claudin-1

ATGAGGATGGC
TGTCATTGG

ATTGACTGGGG
TCATAGGGT

8

4

NM_021101.5

β-defensin-1

GGCCTCAGGTG
GTAACTTTCT

TTCTTCTGGTCA
CTCCCAGC

4

8

NM_005218.4

GAPDH

GAGCCACATCG
CTCAGACAC

CATGTAGTTGA
GGTCAATGAAG
G

8

16

NM_002046.7

Table 2.14: qPCR Reaction Conditions for Gene Expression Analysis.
Step
Enzyme Activation
PCR

Temperature (°C)
95
95
X*
72

Time
10 min
15 s
30 s
30 s

Number of Cycles
1
40

*Annealing temperature of 62°C was used for reactions with TLR1, 64°C with TLR2,
60°C for claudin-1 and β-defensin-1, and 60°C for GAPDH.
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Table 2.15: qPCR Reaction Standards for Gene Expression Analysis.
Target

Human
TLR1,
mRNA

Human
TLR2,
transcript
variant 1,
mRNA

Human
claudin1, mRNA

Human
βdefensin1, mRNA

Human
GAPDH,
transcript
variant 1,
mRNA

Standard Sequence (5′-3′)
TTTTGATTATTCTGGCACTTCCTTGAAGGCCTTGTC
TATACACCAAGTTGTCAGCGATGTGTTCGGTTTTCC
GCAAAGTTATATCTATGAAATCTTTTCGAATATGA
ACATCAAAAATTTCACAGTGTCTGGTACACGCATG
GTCCACATGCTTTGCCCATCCAAAATTAGCCCGTT
CCTGCATTTGGATTTTTCCAATAATCTCTTAACAGA
CACGGTTTTTGAAAATTGTGGGCACCTTACTGAGT
TGGAGACACTTATTTTACAAATGAATCAATTAAAA
GAACTTTCAAAAATAGCTGAAATGACTACACAGAT
GAAGTCTCTGCAACAATTGGATATTAGCCAGA
TAACTACGTTTTCTAAGGAGCAACTTGACTCATTTC
ACACACTGAAGACTTTGGAAGCTGGTGGCAATAAC
TTCATTTGCTCCTGTGAATTCCTCTCCTTCACTCAG
GAGCAGCAAGCACTGGCCAAAGTCTTGATTGATTG
GCCAGCAAATTACCTGTGTGACTCTCCATCCCATG
TGCGTGGCCAGCAGGTTCAGGATGTCCGCCTCTCG
GTGTCGGAATGTCACAGGACAGCACTGGTGTCTGG
CATGTGCTGTGCTCTGTTCCTGCTGATCCTGCTCAC
GGGGGTCCTGTGCCACCGTTTCCATGGCCTGTGGT
ATATGAAAATGATGTGGGCCTGGCTCCAGGCC
AAGCAACCCGTGCCTTGATGGTGGTTGGCATCCTC
CTGGGAGTGATAGCAATCTTTGTGGCCACCGTTGG
CATGAAGTGTATGAAGTGCTTGGAAGACGATGAG
GTGCAGAAGATGAGGATGGCTGTCATTGGGGGTG
CGATATTTCTTCTTGCAGGTCTGGCTATTTTAGTTG
CCACAGCATGGTATGGCAATAGAATCGTTCAAGAA
TTCTATGACCCTATGACCCCAGTCAATGCCAGGTA
CGAATTTGGTCAGGCTCTCTTCACTGGCTGGGCTG
CTGCTTCTCTCTGCCTTCTGGGAGGTGCCCTACTTT
GCTGTTCCTGTCCCCGAAAAACAACCTCTTACCCA
GCCAGTCGCCATGAGAACTTCCTACCTTCTGCTGTT
TACTCTCTGCTTACTTTTGTCTGAGATGGCCTCAGG
TGGTAACTTTCTCACAGGCCTTGGCCACAGATCTG
ATCATTACAATTGCGTCAGCAGTGGAGGGCAATGT
CTCTATTCTGCCTGCCCGATCTTTACCAAAATTCAA
GGCACCTGTTACAGAGGGAAGGCCAAGTGCTGCA
AGTGAGCTGGGAGTGACCAGAAGAAATGACGCAG
AAGTGAAATGAACTTTTTATAAGCATTCTTTTAAT
AAAGGAAAATTGCTTTTGA
GCTCTCTGCTCCTCCTGTTCGACAGTCAGCCGCATC
TTCTTTTGCGTCGCCAGCCGAGCCACATCGCTCAG
ACACCATGGGGAAGGTGAAGGTCGGAGTCAACGG
ATTTGGTCGTATTGGGCGCCTGGTCACCAGGGCTG
CTTTTAACTCTGGTAAAGTGGATATTGTTGCCATCA
ATGACCCCTTCATTGACCTCAACTACATGGTTTAC
ATGTTCCAATATGATTCCACCCATGGCAAATTCCA
TGGCACCGTCAAGGCTGAGAACGGGAAGCTTGTC
ATCAATGGAAATCCCATCAC

Length
(bp)

350

Accession
Number

NM_003263.4

NM_001318787.2
350

350

300

300

NM_021101.5

NM_005218.4

NM_002046.7
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2.9

Toll-like Receptor Function Analysis

To assess the function of Toll-like receptors, such as TLR4, a 4 µL volume of 100 ng/mL
lipopolysaccharide (LPS, an agonist for TLR4; Invivogen) in endotoxin-free water was
placed apically on organotypic, explant cultured, and fresh foreskin tissues on Transwell
inserts. Maintenance Medium (9 mL for organotypic cultures, 600 L for explants) was
placed in the basal Transwell chamber, with tissues incubated in a 37°C, 5% CO2
humidified incubator for 24 hours post LPS application. Basal medium from the culture
was harvested at timed intervals (6, 12, and 24 hours) and stored at -80°C for further
analysis of soluble immune mediators. An IL-8 enzyme-linked immunosorbent assay
(ELISA) kit (Invitrogen) was used as per manufacturer’s protocol, with samples diluted
(1:100) prior to the procedure with provided sample diluent. Samples were then diluted
1:10 during the protocol with provided sample diluent, following the initial 1:100
dilution.

2.10

Tissue Marker and Tight Junction Analysis

The depth of the whole epithelial layer, as well as layers only staining positive for
filaggrin (stratum corneum), and E-cadherin (whole epithelium) were determined.
Additionally, the proportion of the epidermal layer that stained positive for the junction
proteins claudin-1 and E-cadherin was also determined.
To determine tissue depth measurements, a minimum of three fields of view (FOV) of
similar size (within a tissue) were obtained from whole tissue section
immunofluorescence microscope images using ImageJ. FOVs were selected from regions
without breaks or staining artefacts. ROIs were then put through a workflow designed
based on Edfeldt et al, 2020 using CellProfiler cell image analysis software160,161. Briefly,
each FOV was outlined and the epidermis segmented by drawing apical and basal lines
(following the apical epithelial border and basal membrane, respectively) with a
CellProfiler pipeline. A third line was manually drawn onto images denoting the area at
which the stratum corneum begins, based on filaggrin staining. The distances between the
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apical, basal, and filaggrin lines were then determined using a CellProfiler pipeline that
measures the shortest distance between each pixel on the apical line to the basal line,
apical line to filaggrin separator line, basal line to filaggrin separator line, and vice versa.
The average total thickness of the epithelium was determined through this method,
alongside the region between the basement membrane and stratum corneum, and the
stratum corneum itself (Figure 2.3).

Figure 2.3: Process for Determination of Tissue Thickness Measures. Tissues have an
apical, basal, and separator line drawn on their surface. The average mean thickness
measure is then determined between the apical and separator lines, basal and separator
lines, and finally between apical and basal lines. The shortest distance between the two
lines examined is calculated per pixel of each line and averaged to determine this value.
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Percent area coverage (immunoreactivity quantification) was determined using ImageJ,
as follows (Figure 2.4). Four-colour whole tissue section immunofluorescence
microscope images obtained from Section 2.7 were split into individual colour channels,
with the individual channels for E-cadherin and claudin-1 saved for analysis. The
resultant saved images were converted to an 8-bit format, then into greyscale. A
representative image for each marker was used in ImageJ to determine image thresholds
with the “Adaptive Thresholding” plugin. The “Pixel Block Size” parameter was
optimized such that the net-like structure of each marker was captured without picking up
non-positive signals. The “Subtraction” parameter was then optimized thereafter to help
refine the selection of pixels, such that background noise in the image was eliminated.
These two values were kept and used for the script described later in this section. Next,
the area outside the greyscale tissue image was circled manually using the “Free
Selection” tool and eliminated. Images were then subject to the “Percent Signal Coverage
Determination” script (described in Buchanan et al, in press) using the manually
determined “Adaptive Thresholding” values for “Pixel Block Size” and “Subtraction”
described earlier162. These two thresholding values were kept consistent across all tissues
used in the study so as to permit comparison. The script used in this study provided an
output describing the total area covered with positive staining and had to be adjusted as
indicated by the scripts publishers so as to ensure the correct percent area coverage was
determined. The total area for positive marker staining in the whole image was then
divided by the area of the tissue to facilitate this. Tissue area was manually determined by
circling the region of positive staining three separate times in ImageJ using the “Freehand
Selection” tool.
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Figure 2.4: Immunofluorescent Image Immunoreactivity Quantification Steps. (A)
16-bit four-colour immunofluorescent image prior to quantification. (B)
Immunofluorescent image is split into only one channel, then (C) converted to 8-bit,
converted to grayscale, and then subject to manual background removal. (D) Binary
image after processing with immunoreactivity pipeline script, highlighting areas of
positive E-cadherin immunoreactivity.

2.11

Tight Junction Functional Analysis

Organotypic, explant-cultured, and fresh tissues was subject to a permeability assay as
described by Sayedyahossein et al, 2016 to assess tight junction functionality and skin
barrier integrity163. Explanted tissues were placed into 24-well Transwell inserts with the
epidermis side up, had their edges sealed with a 1:1 (vol/vol) mixture of white petrolatum
and paraffin oil (MilliporeSigma), and were fed basally with Maintenance Medium. A
single 10 µL drop of 10,000 kDa AF594-conjugated dextran (Invitrogen; dissolved in 1X
DPBS) was added to the center surface of the tissue of interest. In vitro tissues were
incubated with a 10 µL droplet of 0.3 mg/mL dextran after tissue sealing, while explanted
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tissues were incubated with an 8 µg/mL solution of dextran to account for differences in
culture medium volume required for each tissue type. Tissues were covered using
aluminum foil with a large Kimwipe (Kimtech Science) taped on basally to block light
reflection and incubated for 24 hours in a 37°C, 5% CO2 humidified incubator. Small 100
µL volumes of basal medium were removed at timed intervals (6, 12, 24 hours),
transferred to a covered black microplate, and retained in the incubator until all
timepoints were complete. The fluorescence intensity of the collected samples was then
determined using a Cytation 5 imaging reader (Gen5 3.02 software; both from BioTek) to
quantify the amount of dextran that penetrated through the tissue and into the basal
medium below the Transwell. Experiments contained control tissue without dextran
tracer (negative controls) and medium without tissue or tracer (blank); positive controls
consisted of either medium with dextran either spiked directly into medium or pipetted
onto the apical side of empty Transwell inserts with medium in the basal chamber.
Samples of basal medium were taken from negative and positive controls at the same
time points as experimental Transwells (i.e., containing tissues). To quantify percent
permeation, raw fluorescence values from each experimental Transwell were normalized
to a time-matched positive control, following either Equation 2.1 or 2.2 (dependent on
controls available).

Equation 2.1:
Experimental Well Medium−Average Tissue Negative Control

(Average Medium Only Positive Control−Average Medium Only Negative Control) × 100%

Equation 2.2:
Experimental Well Medium−Average Tissue Negative Control

(Transwell Positive Control at 24 hours−Average Medium Only Negative Control) × 100%
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2.12

Data Analysis

Data was analyzed and graphs assembled using GraphPad Prism (version 8.4.3;
GraphPad Software Inc.) and Stata SE (version 17; StataCorp LLC). Each dataset
obtained in this study was screened for outliers using the robust regression and outlier
removal (ROUT) method (Q = 1%). Data is presented as mean ± standard deviation, and
statistical testing done when sample sets contained at minimum three biological
replicates. When directly comparing means between two independent groupings,
unpaired two-tailed t-tests were used. Comparing two related groupings was done using
paired two-tailed t-tests. A random effects model was used to examine tissue
permeability over time. A confidence level of 95% was selected for each statistical test.
Lastly, comparisons were made in this study between organotypic foreskins and adult
foreskin tissues where possible (as organotypic foreskins are composed of isolated adult
foreskin cells), although this was not possible in all cases. Where such comparisons could
not be made, paediatric foreskin tissue was used as a substitute.
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Chapter 3

3

Results
3.1

Participants

Tissue samples were obtained from two cohorts: (1) adult men (≥18 years of age; n = 10)
undergoing elective circumcision, with no signs or history of genital infections, recent
antibiotic use, or hormone therapy; and (2) boys (<18 years of age; n = 43) undergoing
circumcision for either elective or medically indicated reasons (e.g., treatment of
recurrent balanitis, phimosis, recurrent urinary tract infection, or balanitis xerotica
obliterans). A summary of adult participant demographics is provided in Table 3.1, while
paediatric participant demographics are provided in Table 3.2. Demographics for specific
participant tissues used for 3D organotypic foreskin development or explant culture are
shown in Table 3.3 and Table 3.4 for adult (n = 3) and paediatric (n = 5) participants,
respectively. Two cohorts were assessed in this study as elective cosmetic circumcision,
our main source of foreskin tissue prior to the coronavirus disease 2019 (COVID-19)
pandemic, was no longer permitted due to pandemic-associated restrictions. Medically
indicated circumcision, as occurred for most paediatric participants, was permitted and
thus became our main source of foreskin tissue during the pandemic.
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Table 3.1: Adult Cohort Demographics (n = 10).
Demographic Value
Age (yrs; median, range; n = 9)

24 (20-48)
White
African, Caribbean, or other Black
East Asian
South Asian
Latin American
First Nations
Other/Mixed Ethnicity

Ethnicity

Sexually Active

8/10 (80.0%)
0/10 (0.0%)
0/10 (0.0%)
0/10 (0.0%)
1/10 (10.0%)
0/10 (0.0%)
1/10 (10.0%)
9/10 (90.0%)

Indication for Circumcision

Partial Inability to Retract
Foreskin
Complete Inability to Retract
Foreskin
Cosmetic

3/10 (30.0%)
3/10 (30.0%)
4/10 (40%)

Table 3.2: Paediatric Cohort Demographics (n = 43).
Demographic Value
Age (yrs; median, range; n = 43)

Ethnicity (n = 41)

8.09 (0.94-17.33)
Caucasian
Asian
African American
Middle Eastern
Other

Sexually Active (n = 42)

1/42 (2.4%)
Elective

Indication for Circumcision (n = 43)

Recurrent UTI
Balanitis
d

BXO
Phimosis
Other

c

UTI, Urinary Tract Infection

d

BXO, Balanitis Xerotica Obliterans

29/41 (70.7%)
6/41 (14.6%)
2/41 (4.9%)
4/41 (9.8%)
0/41 (0.00%)

c

5/43 (11.6%)
1/43 (2.3%)
2/43 (4.7%)
0/43 (0.0%)
32/43 (74.4%)
3/43 (7.0%)
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Table 3.3: Demographics of Adult Participants Included in this Study. Demographic
information for adult participants who took part in the study through tissue donation.
Tissues were used for either 3D organotypic foreskin development or explant culture.
Deidentified Participant
e

ADLT 001

ADLT 002

ADLT 009

e

ADLT, Adult

Demographic Value
Age
Ethnicity
Sexually Active
Indication for Circumcision

21
White
Yes
Cosmetic

Age
Ethnicity
Sexually Active
Indication for Circumcision

25
White
Yes
Partial Inability to Retract
Foreskin; Cosmetic

Age
Ethnicity
Sexually Active
Indication for Circumcision

No Response
Latin American/White
Yes
Complete Inability to Retract
Foreskin
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Table 3.4: Demographics of Paediatric Participants Included in this Study.
Demographic information for paediatric participants who took part in the study through
tissue donation. Tissues were used for either 3D organotypic foreskin development or
explant culture.
Deidentified Participant

Demographic Value
Age
Ethnicity
Sexually Active
Indication for Circumcision

8.98
Caucasian
No
Phimosis

PED 039

Age
Ethnicity
Sexually Active
Indication for Circumcision

1.78
Caucasian
No
Phimosis

PED 040

Age
Ethnicity
Sexually Active
Indication for Circumcision

14.15
Caucasian
No Response
Phimosis

PED 041

Age
Ethnicity
Sexually Active
Indication for Circumcision

8.17
African American
No
Elective

PED 043

Age
Ethnicity
Sexually Active
Indication for Circumcision

8.09
Caucasian
No
Phimosis

f

PED 037

f

PED, Paediatric
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3.2
Isolation and Culture of Foreskin Epidermal
Keratinocytes and Dermal Fibroblasts
Cells were isolated from foreskin tissues as described in Gangatirkar et al, 2007, with
modifications made through troubleshooting highlighted in Table 3.5.

Table 3.5: Cell Isolation and Culture Troubleshooting.
Cell Isolation Issue
Tissue epidermis not peeling off
after Dispase II incubation at
4°C.

Change to Protocol
Add one extra incubation step (1 hour;
37°C) before mechanical separation of
tissue layers.
Increase Dispase II volume for
incubation to ensure whole tissue is
covered.
Centrifuge cells at slower speed for

Result
Tissue layers now easily
separate from one another
with minimal effort; yields
whole epidermal sheets.

g

Few keratinocytes or fibroblasts
survive plating and exhibit
slowed growth.

Keratinocytes difficult to detach
from cell culture vessels.

Few keratinocytes survive
passaging protocols; slow
growth once passaged.

Fibroblasts or keratinocytes do
not appear in their respective
cell culture vessel. Cells are
indistinguishable between small
foreskin tissue remnant/debris.

g

RPM, Revolutions per Minute

longer time [114 x g (500 RPM ), 8
minutes; from 524 x g (1500 RPM), 5
minutes].
Plate all isolated cells into smaller cell
culture vessel (e.g., one well of a 24well plate) instead of multiple cell
culture vessels.
Incubate cells with 0.5 mM EDTA in
1X DPBS before adding detachment
enzyme.
Incubate with Accutase enzyme instead
of 0.05% or 0.25% Trypsin-EDTA
solutions.
Centrifuge cells at slower speed for
longer time [114 x g (500 RPM), 8
minutes; from 524 x g (1500 RPM), 5
minutes].
Incubate with Accutase enzyme instead
of 0.05% or 0.25% Trypsin-EDTA
solutions.
Incubate cell culture vessel without any
media changes/disruptions.

Increased cell attachment,
less cell death after
isolation, and faster
cellular proliferation.

Almost all keratinocytes
detach from cell culture
vessels.

More cells attach to cell
culture vessels after
passaging. Increased
growth rate.

Cells should become
visible and begin dividing
within 2-3 weeks post
isolation.
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3.3

Immortalization of Foreskin Keratinocytes

Isolated foreskin keratinocytes were transduced with a retroviral vector encoding HPV16
E6 and E7 oncogenes to prolong the ability to propagate these cells for developing the
organotypic foreskin model. Cells were retained pre-transduction as well as post
transduction for comparison to one another. This comparison would ensure the donor’s
isolated keratinocytes were not previously infected with HPV16 before the study
commenced, which could impact the isolated keratinocytes phenotype in a non-controlled
way. Additionally, this confirms successful cell transduction through amplification of the
viral insert.
Isolated foreskin keratinocytes that underwent the immortalization procedure were
cultured with Geneticin antibiotic to select for transduced cells and were harvested for
PCR comparison when little to no cellular death was observed during culture. Figure 3.1
shows an initial test of the procedures used to extract genomic DNA and amplify the
HPV16 E6E7 insert on a transduced paediatric sample with no matched non-transduced
keratinocytes. Cells were transduced at passage 1 and harvested 22 days later at passage
3. The insert amplified in this test was verified as the HPV16 E6E7 insert (773 base
pairs) through sequencing the PCR amplicon and comparing this sequence via in silico
alignment to the HPV16 E6E7 insert.
If available, non-transduced, snap frozen keratinocytes were compared to transduced
keratinocytes as shown in Figure 3.2. Transduced cells from ADLT 001 and 002 were
used for developing and troubleshooting the 3D organotypic foreskin model, while
transduced paediatric cells (PED 010, 022, 023, 024, 025, 028) were frozen with patientmatched fibroblasts for future use.
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Figure 3.1: Initial Test of the Keratinocyte Transduction PCR Verification
Procedure. Genomic DNA isolated from transduced PED 010 keratinocytes subject to
PCR amplification for the HPV16 E6E7 insert. Amplicon was run on a 1% agarose gel
and compared to a commercially available DNA ladder for amplicon size. Amplicon was
subject to sequencing and in silico sequence alignment analysis to verify amplicon
identity. Amplicon size, 773 bp; Neg, negative control (no DNA included in PCR step);
+, transduced cell PCR product.
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Figure 3.2: Verification of Keratinocyte Transduction via PCR. Genomic DNA
isolated from non-transduced and transduced paediatric and adult keratinocytes was
subject to PCR amplification for the HPV16 E6E7 insert. Amplicon was run on a 1%
agarose gel and compared to a commercially available DNA ladder for amplicon size.
Amplicon size, 773 bp; Neg, negative control (no DNA included in PCR step); -, nontransduced cell PCR product; +, transduced cell PCR product.
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3.4

Developing Organotypic Foreskin Models

Artificial foreskin tissues were created as described in Gangatirkar et al, 2007, with
modifications made through troubleshooting highlighted in Table 3.6. The stages of
organotypic foreskin model development are shown in Figure 3.3, alongside a
representative image of cross-sectioned, immunofluorescently stained mature organotypic
foreskin. In this figure, it is shown that the collagen matrix embedded with fibroblasts
actively contracts over one week of culture in Cast Feed Medium (Figure 3.3A and B).
Additionally, keratinocytes used to seed the surface (using the modifications in Table 3.3)
are also observed to form a fully confluent monolayer on the surface of the collagen, as
the apical surface becomes opaque and white in colouration (in sharp contrast to the
reddish-pink collagen apical surface; Figure 3.3C and D). Examination of microscopy
images show organotypic foreskins have multiple layers of cell nuclei (blue) throughout
the tissue epidermal region (Figure 3.3E) that express both E-cadherin and filaggrin.
Filaggrin can be found in the more apical aspect of the model, similar to matured
terminally differentiated keratinocytes in vivo. In comparison to foreskin tissue
immediately frozen after circumcision surgery (representative images in Figure 3.4),
organotypic foreskins express E-cadherin and filaggrin proteins in similar suprabasal
layers as compared to in vivo tissue. It is also possible to identify each of the epithelial
layers in the immediately frozen foreskin tissue, and, although less clearly, in the
organotypic epidermis. Cell layers were identified based on morphology, and the location
of the basal collagen layer (“dermis”) and apical filaggrin staining (stratum corneum). Ecadherin expression also appears more diffuse throughout the organotypic model, in
comparison to the cell surface expression (net-like) in the immediately frozen tissue.
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Table 3.6: Organotypic Foreskin Model Troubleshooting Summary.
Organotypic Foreskin
Development Issue
Minimal cellular collagen
contraction; fibroblasts very
sparse within the collagen
hydrogel.

Keratinocytes not growing on
cellular collagen surface.

Keratinocytes growing on
cellular collagen surface but
forming patches instead of a
confluent monolayer.

Change to Protocol
Increase cellular layer cell
suspension concentration from
2.3 x 105 cells/mL to 3.28 x 105
cells/mL.
Grow keratinocyte seeded
collagen for one week in K-SFM
Complete medium, prior to one
week of culture in
Epidermalization Medium.
Increase keratinocyte
concentration in seeding
procedure. Instead of seeding 30
µL of cells at 1.667 x 106
cells/mL, seed 50 µL of cells at
16.67 x 106 cells/mL.
Add the 50 µL droplet of
keratinocytes as individual 10 µL
droplets evenly across the surface
of the collagen, rather than
directly in the center.
Increase growth time of the
dermal equivalent in K-SFM
Complete medium from seven to
10 days.

Result
Collagen contracts by ¼ its
original size after seven days of
culture. Fibroblasts now more
tightly packed together in the
collagen hydrogel.
Keratinocytes now growing and
forming patches of cells on the
top of cellular collagen layer.

Keratinocytes now forming
homogenous, confluent
monolayer visible to the naked
eye across the entire surface of
the cellular collagen.
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Figure 3.3: Developmental Stages of the Organotypic Foreskin Model. (A) Collagen
and fibroblast mixture after having been cast into a 6-well Transwell. (B) Collagen and
fibroblast mixture after seven days of culture; arrow shows the contraction of collagen
away from the Transwell periphery. (C) Collagen surface after having been seeded with
keratinocytes and cultured for 10 days until reaching 100% confluence. (D) Fully mature
3D organotypic foreskin. (E) Representative image of a fully matured organotypic
foreskin cryosectioned, immunofluorescently stained, and imaged to examine presence of
structural markers. Filaggrin (green) staining highlights terminally differentiated
keratinocytes of the stratum corneum; E-cadherin (red) staining highlights maturing
keratinocytes and adherens junction presence; Nuclear staining (blue) highlights cell
nuclei. Note that collagen fibres may autofluoresce green, alongside the Transwell
membrane located basally (white arrow). Organotypic constructs were cultured without
mechanical agitation.
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Figure 3.4: Immunofluorescence-based Comparison between Paediatric Foreskin
Tissue Frozen Immediately after Circumcision and Organotypic Foreskin. Sections
of paediatric foreskin and organotypic foreskin are compared to highlight the presence or
absence of constituent skin layers. Both tissues are stained for filaggrin (green; terminally
differentiated keratinocytes), E-cadherin (red; maturing keratinocytes and adherens
junctions) and nuclei (blue). Note that collagen fibers may autofluoresce green.
Organotypic foreskin was cultured without mechanical agitation.

To ensure we had the correct comparator for organotypic foreskins, immunofluorescence
images were quantified using the previously described depth quantification pipeline
(Chapter 2.10). Adult and paediatric participant thickness and immunoreactivity metrics
were compared between tissues isolated from the inner vs. outer aspects of the foreskin
(Figure 3.5). Quantification included (1) E-cadherin immunoreactivity thickness, (2)
filaggrin immunoreactivity thickness, (3) Total epithelial thickness, and (4) the
proportion of the epithelium immunoreactive for E-cadherin. Tissues immediately frozen
after circumcision were examined in this analysis. Immediately frozen paediatric inner
and outer foreskin tissues show no detectable difference in overall thickness for the Ecadherin layer (inner: 35.7 ± 20.0 µm, outer: 34.8 ± 2.5 µm; p = 0.9; Figure 3.5A),
filaggrin layer (inner: 12.5 ± 6.6 µm, outer: 14.9 ± 4.4 µm; p = 0.5; Figure 3.5B), total
epithelium (inner: 48.2 ± 24.8, outer: 59.6 ± 24.3; p = 0.5; Figure 3.5C) or E-cadherin
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immunoreactivity (inner: 38.0 ± 13.1%, outer: 34.1 ± 11.8%; p = 0.6; Figure 3.5D).
Preliminary results for adult tissues suggest that they may show some difference between
inner and outer foreskin for E-cadherin (inner: 55.8 µm, outer: 99.3 µm), filaggrin (inner:
14.1 µm, outer: 24.1 µm), and total epithelial thickness (inner: 69.9 µm, outer: 123.5
µm), as well as E-cadherin immunoreactivity (inner: 35.8%, outer 21.0%).
Adult immunofluorescence images were subsequently quantified using the depth
quantification pipeline based on the observed differences between paediatric and adult
foreskins, and because organotypic foreskins were made with adult cells (Figure 3.6). As
cells used to construct the organotypic foreskin were from both the inner and outer
foreskin, both of these measures were included on the same graph. These inner and outer
foreskin measures were from the same participant. Adult foreskin tissues either
immediately frozen after circumcision or cultured for seven days as an explant were
compared to organotypic foreskins. The organotypic foreskin produced a similar
thickness of cells expressing E-cadherin when compared to fresh tissue (117.9 µm and
77.5 ± 30.8 µm, respectively), and a thicker layer of cells expressing filaggrin (46.7 µm
and 19.1 ± 7.1 µm, respectively; Figures 3.6A and B). The organotypic model also
produced a measurable total epithelial layer when compared to fresh tissues (168.5 µm
and 96.7 ± 37.9 µm, respectively; Figure 3.6C). The organotypic model and fresh tissues
showed E-cadherin immunoreactivity as well (55.6% and 28.4 ± 10.4%, respectively;
Figure 3.6D). Of note, I was unable to quantify seven-day cultured explant tissue through
this approach (Figure 3.6A, B, C, and D). As adult foreskin tissues were difficult to
source during the latter portion of this study due to the COVID-19 pandemic, these two
datasets are incomplete (Figure 3.5 and Figure 3.6). More biological replicates are
required to draw statistical conclusions from these results.
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Figure 3.5: Quantifying Layer Thickness and E-cadherin Immunoreactivity
between Adult and Paediatric Inner and Outer Foreskin Tissues. The thickness of
(A) E-cadherin, (B) filaggrin, and (C) the epithelial layer was quantified between inner (n
= 3 paediatric, n = 1 adult) and outer (n = 3 paediatric, n = 1 adult) foreskin tissue
immediately frozen after circumcision surgery. (D) The percent surface area coverage by
E-cadherin pixels was then quantified for these tissue images. Shown are mean values
and standard deviation. Each point was obtained from three fields of view (A, B, C) or
one representative section of a complete image (D). Statistical comparisons made by
unpaired t-test. ns, non-significant.
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Figure 3.6: Quantifying Layer Thickness and E-cadherin Immunoreactivity
between Adult Foreskin Tissues and the Mature In Vitro Organotypic Foreskin
Model. The thickness of (A) E-cadherin, (B) filaggrin, and (C) the epithelial layer was
quantified between foreskin tissue immediately frozen after circumcision surgery (1
participant, n = 2 samples; inner and outer foreskin), tissue cultured for seven days in
medium (1 participant, n = 1), and an organotypic foreskin tissue (n = 1). (D) The percent
surface area coverage by E-cadherin pixels was then quantified for these tissue images.
Shown are mean values and standard deviation. Each point was obtained from three fields
of view (A, B, C) or one representative section of a complete image (D). NQ, not
quantifiable.
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3.4
Characterizing Innate Immune Defense Capability
and Functionality
To quantify the abundance of mRNAs for genes involved in innate immune defense,
qPCR experiments were optimized for primer concentration and annealing temperature
using a standard curve. The optimized mean reaction efficiency and linearity for the
standard curve are shown in Table 3.7. The qPCR assay for TLR1 had an efficiency of
99.8 ± 3.5%, and linearity of 0.991 ± 0.005. TLR2 qPCR assay efficiency was 94.1 ±
1.8%, with linearity at 0.998 ± 0.001. β-defensin-1 efficiency and linearity were 104.3 ±
1.1% and 0.996 ± 0.001 respectively. GAPDH efficiency and linearity were 92.8 ± 2.5%
and 0.998 ± 0.001, respectively.
Following this, the gene expression levels of TLR1, TLR2, β-defensin-1, and GAPDH
were quantified in fresh foreskin tissue, tissue cultured in medium for seven days, and
organotypic foreskins (Figure 3.7). The number of mRNA copies calculated for these
genes were normalized across tissues by determining the number of copies per 10,000
copies of GAPDH. This was performed so as to examine the effect of culturing on the
expression of these innate immune system genes. There was no detectable difference
between fresh or seven-day explant cultured tissue log10 copy numbers for TLR1, TLR2,
or β-defensin-1 mRNA (p = 0.3, 0.6, and 0.9 respectively; Figure 3.7). Lastly,
organotypic foreskins appear to show a decrease in TLR1 copy numbers compared to
fresh and seven-day explant tissue, but similar TLR2 and β-defensin-1 copies compared
to fresh tissue. PED fresh tissue copy numbers were 3.3 ± 0.8 for TLR1, 3.0 ± 0.6 for
TLR2, and 4.3 ± 0.4 for β-defensin-1. PED seven-day explant copy numbers were 2.6 ±
0.1 for TLR1, 2.7 ± 0.2 for TLR2, and 4.2 ± 0.8 for β-defensin-1. Lastly, ADLT
organotypic foreskin copy numbers were 2.1 ± 0.1 for TLR1, 3.0 ± 0.4 for TLR2, and 4.2
± 0.4 for β-defensin-1.
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Table 3.7: Optimized qPCR Reaction Efficiency and Standard Curve Linearity for
TLR1, TLR2, β-defensin-1, and GAPDH. Efficiency of amplification as measured with
a standard curve, as well as standard curve linearity are shown for successful qPCR
assays used to detect copies of TLR1 (n = 10), TLR2 (n = 9), β-defensin-1 (n = 8), and
GAPDH (n = 3). Shown are mean values and standard deviation.
Gene
TLR1
TLR2
β-defensin-1
GAPDH

Reaction Efficiency
99.78 ± 3.54%
94.13 ± 1.82%
104.34 ± 1.06%
92.77 ± 2.46%

Linearity
0.991 ± 0.005
0.998 ± 0.001
0.996 ± 0.001
0.998 ± 0.001
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Figure 3.7: Innate Immune System Gene Expression Comparison between
Paediatric Explant-Cultured and Adult Organotypic Foreskin Tissues over Culture
Time. The log10 copy number of (A) TLR1, (B) TLR2, and (C) β-defensin-1 was
quantified between fresh (n = 3, paediatric), seven-day cultured (n = 3, paediatric) and
organotypic (n = 2, adult) foreskin tissues. Matched tissues are indicated by same-point
colouration and shape across groupings. Shown are mean values and standard deviation.
Each point was obtained from three technical replicates (A, B, and C). Statistical
comparisons made by paired t-test. ns, non-significant.
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Changes in expression of innate immune defense genes after exposure to LPS (100
ng/mL) were quantified across fresh, seven-day, and organotypic tissues (Figure 3.8).
There were too few biological replicates to include data from organotypic foreskin tissues
in statistical analyses. There was no detectable difference in the mean log10 copy numbers
for TLR1, TLR2, or β-defensin-1 (p = 0.2, 0.1, and 0.7, respectively) between fresh
foreskin tissues stimulated with LPS and their unstimulated controls (Figure 3.8). This
was also the case for LPS stimulated seven-day explant foreskin tissues and unstimulated
controls (p = 0.6, 0.4, and 0.7 respectively). Organotypic foreskins appeared to show no
difference in mean log10 copy numbers for these same genes when comparing LPS
stimulated and unstimulated tissue.
Tissues examined in the TLR1 analysis (no LPS vs. with LPS) included PED fresh tissue
(3.5 ± 1.4 vs. 2.4 ± 0.6), PED seven-day explant tissue (2.8 ± 0.5 vs. 2.7 ± 0.1) and.
organotypic foreskins (2.1 ± 0.05 vs. 1.8 ± 0.3). Tissues examined in the TLR2 analysis
included PED fresh tissue (3.2 ± 0.8 vs. 2.5 ± 0.5), PED seven-day explant tissue (3.4 ±
0.3, vs. 3.1 ± 0.6), and organotypic foreskins (3.0 ± 0.4 vs. 2.7 ± 0.1). Tissues examined
in the β-defensin-1 analysis included PED fresh tissue (4.4 ± 0.5 vs. 4.4 ± 0.2), PED
seven-day explant tissue (4.5 ± 0.5 vs. 4.6 ± 0.8), and organotypic foreskins (4.2 ± 0.4 vs.
4.1 ± 0.5).
Additional organotypic cultures are required (Figure 3.7 and 3.8) to allow statistical
analysis of this data set in comparison to other tissue types.
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Figure 3.8: Innate Immune System Gene Expression Comparison between
Paediatric Explant-Cultured and Adult Organotypic Foreskin Tissues Exposed to
LPS. The log10 copy number for (A) TLR1, (B) TLR2, and (C) β-defensin-1 was
quantified between fresh (n = 3, paediatric), seven-day cultured (n = 3, paediatric) and
organotypic (n = 2, adult) foreskin tissues exposed to LPS and compared to matched noLPS controls. Matched tissues are indicated by same-point colouration and shape across
groupings. Shown are mean values and standard deviation. Each point was obtained from
three technical replicates (A, B, and C). Statistical comparisons made by paired t-test. ns,
non-significant.
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In addition to innate immune gene expression, the effect of LPS on release of the
chemokine IL-8 into basal chamber medium was assessed. At 6 hours (Figure 3.9A),
fresh paediatric tissue did not secrete detectable IL-8 irrespective of LPS exposure.
Seven-day explants stimulated with LPS for 6 hours did not appear to show any
difference in log10 IL-8 secretion (3.9 ± 0.07, no LPS vs. 4.1 ± 0.4, LPS). Organotypic
foreskin showed increased IL-8 secretion when stimulated with LPS for 6 hours (0, no
LPS vs. 3.6, LPS,). 12 hours of LPS exposure (Figure 3.9B) did not cause differences in
IL-8 secretion in fresh (3.8 ± 0.3, no LPS vs. 3.7 ± 0.1, LPS) and seven-day cultured
explant (4.4 ± 0.2 no LPS; 4.1 ± 0.2) foreskin. Additionally, the organotypic foreskin at
12 hours secreted more IL-8 compared to unstimulated controls (2.6, no LPS vs. 4.0 ±
0.7, LPS). 24 hours of LPS exposure (Figure 3.9C) did not induce differences in fresh
(4.7 ± 0.03, no LPS vs. 4.5 ± 0.2, LPS) and seven-day cultured explant (4.8 ± 0.01, no
LPS vs. 4.2 ± 0.8, LPS) IL-8 secretion. The organotypic tissue also secreted IL-8 at a
level comparable to unstimulated control tissues (3.7, no LPS; 3.3 ± 0.5, LPS). More
biological replicates are required (Figure 3.9A, B, and C) to make any statistical
conclusions regarding the impact of LPS at the given concentration and the secretion of
soluble immune mediator IL-8.
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Figure 3.9: IL-8 Secretion as Compared Between Paediatric Explant-Cultured and
Adult Organotypic Foreskin Tissues Stimulated with LPS. The log10 IL-8
concentration in basal compartment medium was quantified at (A) 6 hours, (B) 12 hours,
and (C) 24 hours post LPS administration. These values were compared to matched nonstimulated controls. (A, B, and C) This comparison was between fresh (n = 2, paediatric)
and seven-day cultured foreskin tissue (n = 2, paediatric); as well, the adult in vitro model
was compared to these tissues (A: n = 1 unstimulated and stimulated; B: n = 1
unstimulated, n = 2 stimulated; C: n = 1 unstimulated, n = 2 stimulated tissues). Shown
are mean values and standard deviation. Each point was obtained from three technical
replicates (A, B, and C). Samples were not included in this dataset if they showed IL-8
contamination in their corresponding basal medium-only negative control. NQ, not
quantifiable.
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3.5

Characterizing Tissue Barrier Functionality

Foreskin tissue immediately frozen after circumcision and seven-day cultured tissue were
subject to immunofluorescent staining and imaging so as to discern the presence of tight
junction marker claudin-1 in tissue cultured with or without LPS (representative fourcolour images shown in Figure 3.10, foreskin tissue comparison in Figure 3.11). To
compare across paediatric and adult participants as before, inner and outer paediatric and
adult foreskin tissues were immunostained and quantified in terms of claudin-1 epithelial
immunoreactivity, as shown in Figure 3.12. There was no detectable difference in the
immunoreactivity of claudin-1 between inner (47.9 ± 13.9%) and outer (48.8 ± 16.5%)
paediatric foreskin tissues (p = 0.9). It appeared as though there was increased claudin-1
immunoreactivity for adult inner foreskin compared to the outer foreskin (46.9% vs.
26.8%), but more biological replicates are required to know if this is representative of all
men.
Note that I was unable to immunostain LPS stimulated organotypic cultures due to
COVID-19 pandemic-mediated time constraints and restrictions (Figure 3.11). Similarly,
it was not possible to quantify organotypic foreskin cultures using the established
pipelines mentioned in Chapter 2 for the same reason.
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Figure 3.10: Representative Immunofluorescent Images of Immediately Frozen
Foreskin Tissues. Representative Foreskin tissues from one paediatric participant are
shown. Individual (A) Yellow, (B) blue, (C) red, and (D) green channels are shown for
image E.
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Figure 3.11: Representative Immunofluorescent Imaging of Foreskin Explant
Tissues Cultured either without or with LPS. Representative images of fresh cultured
foreskin tissue either cultured without (A) or with (B) LPS are shown next to that of
seven-day cultured explant tissue cultured without (C) or with (D) LPS. E shows a
representative image of an organotypic foreskin culture without LPS exposure.
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Figure 3.12: Claudin-1 Immunoreactivity Comparison between Paediatric and
Adult Inner and Outer Foreskin Tissues. Representative images of paediatric inner (A)
and outer (B) foreskin tissues are shown next to that of adult inner (C) and outer (D)
foreskin tissues. Tissues were frozen immediately after circumcision surgery. (E) The
percent surface area coverage by claudin-1 pixels was quantified between inner (n = 5
paediatric, n = 1 adult) and outer (n = 4 paediatric, n = 1 adult) foreskin tissue
immediately frozen after circumcision surgery. Shown are mean values and standard
deviation. Each point was obtained from one representative section of a complete image.
Statistical comparison made by unpaired t-test. ns, non-significant.
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Tissues were then subject to an optimized (efficiency and linearity of the standard curve
shown in Table 3.8) qPCR assay to determine the number of mRNA copies for the tight
junction protein claudin-1 in fresh, seven-day cultured, and organotypic foreskin tissues
(Figure 3.13). The efficiency and linearity of this assay was 94.4 ± 2.3% and 0.998 ±
0.001, respectively.

Table 3.8: Optimized qPCR Reaction Efficiency and Standard Curve Linearity for
Claudin-1. Efficiency of amplification as measured using a standard curve, as well as
standard curve linearity are shown for successful qPCR assays used to detect copies of
claudin-1 (n = 8). Shown are mean values and standard deviation.
Gene
Claudin-1

Reaction Efficiency
94.4 ± 2.3%

Linearity
0.998 ± 0.001

There were no statistically significant, detectable differences in claudin-1 mRNA
between tissue types (p = 0.7; Figure 3.13). Organotypic foreskins appeared to show
similar claudin-1 mRNA copies as snap frozen, fresh, and seven-day explant cultured
tissues. Tissues used in the analysis had log10 claudin-1 mRNA copy numbers of 3.2 ±
0.2 (PED fresh tissue), 3.0 ± 0.3 (PED seven-day explant), and 3.3 ± 0.2 (ADLT
organotypic). Next, the effect of LPS on claudin-1 mRNA was assessed (Figure 3.14).
There were no detectable, statistically significant differences between fresh tissues, as
well as seven-day explants across LPS treatment (p = 0.9 fresh tissues; p = 0.5 seven-day
explant tissues). As well, organotypic foreskins appeared to show no difference in
claudin-1 copy numbers when stimulated with LPS. Log10 claudin-1 mRNA copy
numbers (no LPS vs. with LPS) include 3.2 ± 0.1 vs. 3.2 ± 0.1 (PED fresh tissue), 3.1 ±
0.5 vs. 3.1 ± 0.5 (PED seven-day explant), and 3.3 ± 0.2 vs. 3.1 ± 0.1 (ADLT
organotypic).
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Figure 3.13: Claudin-1 Gene Expression Comparison between Paediatric Foreskin
Tissue and Adult Organotypic Foreskins. The log10 copy number for claudin-1 was
quantified between fresh (n = 3, paediatric), seven-day cultured (n = 3, paediatric) and in
vitro organotypic (n = 2 adult) foreskin tissues. Shown are mean values and standard
deviation. Each point was obtained from three technical replicates. Matched tissues are
indicated by same-point colouration and shape across groupings. Statistical comparison
made by paired t-test. ns, non-significant.
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Figure 3.14: Claudin-1 Gene Expression Comparison between Paediatric Foreskin
Tissues and Adult Organotypic Foreskins Exposed to LPS. The log10 copy number for
claudin-1 was quantified between fresh (n = 3, paediatric), seven-day cultured (n = 3,
paediatric) and organotypic (n = 2 adult) foreskin tissues exposed to LPS and compared
to matched no-LPS controls. Shown are mean values and standard deviation. Each point
was obtained from three technical replicates. Matched tissues are indicated by same-point
colouration and shape across groupings. Statistical comparisons made by paired t-test. ns,
non-significant.
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To determine the barrier capability of fresh, seven-day cultured, and organotypic
foreskin, tissues were tested on their ability to exclude a high molecular weight
fluorescent tracer molecule (dextran) applied apically to the stratum corneum over a
period of 24 hours (basal media sampled at 6, 12 and 24 hours; Figure 3.15A). Fresh
foreskin tissue permeability is not significantly different over time (0.16 ± 0.28%
permeation per hour, p = 0.6), whereas seven-day explant tissue does increase in
permeability over time (1.4 ± 0.2% permeation per hour, p = 0). Similarly, organotypic
tissue permeability also increases over time (1.5 ± 0.4% permeation per hour, p = 0).
Tissues included in this analysis (mean ± standard deviation) included PED fresh tissue at
6, 12, and 24 hours (13.8 ± 2.5%, 13.2 ± 2.7%, and 16.3 ± 12.1%, respectively), PED
seven-day explant tissue at 6, 12, and 24 hours (34.4 ± 30.7%, 44.7 ± 27.3%, and 59.6 ±
20.8%), and lastly organotypic foreskins (45.4 ± 21.8%, 63.8 ± 33.1%, and 74.8 ±
27.4%). Organotypic foreskin cultures used in the analysis are shown in Figure 3.15B and
C. Organotypic foreskins in both images appear disorganized with no clear tissue
structure or expression of E-cadherin, claudin-1, or filaggrin.
The preliminary results highlighted in this chapter suggest organotypic foreskins can
mimic the stratification of in vivo tissue, while retaining the expression of innate immune
mediators and adherens junctions that play a role in maintaining tissue structure. As well,
they provide a sterile, physiologically relevant surface suitable for bacterial inoculation.
This is in stark contrast to seven-day cultured foreskin tissue, which loses tissue integrity
and does not provide a sterile environment to inoculate the foreskin microbiota for longterm culture.
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Figure 3.15: Permeability Comparison between Paediatric Foreskin Tissues and
Adult Organotypic Foreskins. The percent permeation by 5 kDa fluorescent dextran
applied to the stratum corneum was quantified for fresh (n = 3 paediatric) and
organotypic (n = 2 adult) foreskin tissues (A). Each point in A represents a single
participant assayed in triplicate, and matched tissues are indicated by same-point
colouration and shape across groupings. B and C shows representative images of the
organotypic foreskin cultures used for this assay (ADLT 001 is shown in B, represented
by pink data points in A; ADLT 002 is shown in C, represented by orange data points in
A). Statistical comparisons were made with a random effects model.
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Chapter 4

4

Discussion
4.1

Cell Isolation and Culture

Primary fibroblasts and keratinocytes were isolated from both adult and paediatric
foreskin tissues as described in Chapter 2. Troubleshooting was required to optimize this
procedure. First, mechanical separation of the dermis from the epidermis after overnight
Dispase II incubation was not successful in most cases, especially with paediatric tissues.
Changes were made (Chapter 3) which included adding an additional 37°C, 1-hour
incubation step after 4°C overnight incubation with Dispase II, and also increasing
Dispase II volume during the incubation. Both paediatric and adult tissue layers were able
to be more easily separated after this which is attributable to both enzyme kinetics and
the selective (collagen type IV) proteolytic activity of Dispase II164. The 37°C incubation
step can increase the enzyme-catalyzed collagen Type IV breakdown rate at the basement
membrane165. By increasing the volume of the enzyme solution, the entire tissue surface
(dermis side up) was in greater overall contact with the enzyme, increasing Dispase II
access (and thus enzyme activity) to its collagen Type IV substrate at the basement
membrane166. Some pieces (particularly those from paediatric participants) still exhibited
little to no layer separation, however. Future directions may include further optimization
of the time the tissue spends in contact with Dispase enzyme at each reaction temperature
above, or empiric testing of mixed incubation temperatures and times on tissue
separation. Alternatively, incubation overnight using cold 0.25% trypsin without EDTA
could be done as this has also been shown to separate the dermis and epidermis of
newborn mouse skin167.
During keratinocyte isolation, keratinocyte viability was initially very low. Few
keratinocytes were able to survive the plating procedure, and those that did exhibited
slow growth. To increase cell viability, cells were centrifuged at a lower speed (114 vs.
524 x g) and plated at a higher density than recommended in the original protocol by
Gangatirkar et al, 2007 (5.3 x 104 vs. 2.6 x 104 cells/cm2). By decreasing centrifugation
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speed, keratinocytes were able to be pelleted and separated from the 0.05% TrypsinEDTA enzyme solution used to extract cells from the epidermal sheet while reducing
cellular damage168. Although, to my knowledge, the specific centrifugation speed at
which keratinocytes experience damage has not been published, this has been
documented in other, more fragile cells such as adipocytes (504 – 2016 x g [1500 – 3000
RPM] for three minutes damaged and lysed cells)169. Plating cells at a higher density
allowed for a higher concentration of cell-produced growth factors in the medium used to
culture the cells, increasing growth and proliferation. To further improve this process,
primary keratinocytes could be cultured with irradiated 3T3 feeder cells (cells unable to
divide) which are primarily used in culture applications to provide additional growth
factors in cell culture medium170. Additionally, increases in K-SFM Complete growth
factors BPE and rEGF may increase the proliferative ability of primary isolated
keratinocytes without relying on 3T3 fibroblast produced growth factors171–173.
Keratinocytes were also difficult to detach from cell culture vessels with trypsin, and
upon any detachment, viability and growth were low and slow once replated. This was
suspected to be due to firm adherence of the keratinocytes to the cell culture vessel
plastic, and cellular damage due to long trypsin incubation followed by centrifugation.
Both the use of trypsin and centrifugation at high speeds can reduce cell viability168,174.
Cells that are damaged during these processes may additionally require a recovery period
after replating before they start to divide once again. Literature review indicated that
incubating the keratinocyte cell monolayer with a solution of 0.5 mM EDTA in 1X DPBS
before enzyme treatment would help to dissociate cell-cell and cell-substrate
interactions,175. In addition, Accutase enzyme was added to cell culture vessels after
EDTA to further dissociate cells. Accutase is composed of proteolytic and collagenolytic
enzymes allowing it to mimic both trypsin and collagenase but at a greater efficiency,
allowing its use at lower concentrations; this, according to the manufacturer, results in
gentler and less toxic cell dissociation (Innovative Cell Technologies, Inc.). Afterward,
cells were centrifuged at 114 x g (700 RPM) for 8 minutes compared to the original 524 x
g (1500 RPM) for 5 minutes to decrease cellular damage168. Keratinocytes that were once
firmly attached were able to be detached and replated successfully at higher densities
when subject to this technique.
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Lastly, keratinocytes may oftentimes not be visible or distinguishable from dead cells and
small cellular debris remaining after the filtration step during cell isolation. Increased
undisturbed culture time was necessary to promote cell growth and proliferation. It was
suspected that these cells were damaged during the isolation protocol and required time
to undergo growth after plating in cell culture vessels. By leaving the keratinocytes in the
cell culture vessel over a period of 2-3 weeks with no disturbance or media change, cells
started dividing and forming distinct colonies distinguishable from cellular debris. This
could be due to low cell viability and density after isolation and thus decreased secretion
of cell growth factors imperative for stimulating cell growth and proliferation.
Additionally, cells may have been stripped of surface receptors due to trypsin treatment
during isolation which may reduce initial cellular response to factors that require surface
receptors176. Future directions and optimizations at this stage include plating isolated
keratinocytes onto irradiated 3T3 fibroblast feeder cells for growth factor secretion, or
possibly using an enzyme that does not strip cells of surface receptors during the isolation
procedure. This may increase the concentration of cell growth factors necessary for
keratinocyte recovery and proliferation, while maintaining the receptors to detect them.
This could thus speed up the time between isolation and establishment of a healthy,
confluent culture of cells.

4.2

Immortalization of Foreskin Keratinocytes

Primary human keratinocytes undergo cellular senescence after approximately 10
doublings177. To maximize keratinocyte longevity for this project, it was necessary to
immortalize these cells such that they can continue dividing and surpass this limitation.
To do this, primary isolated keratinocytes were infected with a replication incompetent
retroviral vector encoding HPV16 E6 and E7 oncogenes, as well as a resistance gene for
the antibiotic neomycin, as shown in Figure 4.1178. The packaging cell line used for this
vector has helper virus DNA containing several alterations crucial for ensuring it remains
replication incompetent, such as removal of a small portion of the 5′ long terminal repeat
(LTR), replacement of the 3′ LTR with a simian virus 40 (SV40) polyadenylation signal,
and deletion of the retroviral packaging signal178. This acts to ensure the vector does not
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generate helper virus, and safeguards against packaging signal transfer between the
vector insert and retrovirus genome178. Should RNA containing helper virus genes get
packaged into virions, these alterations prevent their transmission as many of the signal
elements required for reverse transcription and integration are missing178. There is
additionally a stop codon inserted into the vector insert gag start codon, preventing
production of helper virus by thwarting recombination between the vector sequence and
the helper virus genome (containing the viral packaging signal)178. It would thus be
highly unlikely for replication competent virus to be generated in our study. At least one
recombination event in a short region of homology at the 5′ end of the vector and one
nonhomologous recombination event between the vectors 3′ end and the helper virus
genome would be necessary to do so178.
The E6 and E7 oncogenes, when successfully transduced into keratinocytes, extend the
lifespan of the cell through production of E6 and E7 oncoproteins179. E6 oncoprotein will
induce tumour suppressor p53 degradation, while activating human telomerase reverse
transcriptase (hTERT), the catalytic subunit of telomerase (Figure 4.2)180,181. E7
oncoprotein inhibits the tumour suppressor protein retinoblastoma (pRb; Figure 4.2)179–
181

. In combination, it is the activation of hTERT by E6 and degradation of pRb by E7

that induces cellular immortalization180. Geneticin antibiotic was applied to culture
medium and used to select transduced cells as it selects against eukaryotic cells through
blocking peptide synthesis, and resistance can be conferred through expression of a
neomycin resistance gene182–184. As a result, successfully transduced cells exhibited
Geneticin resistance through incorporation of the neomycin resistance gene, while nontransduced cells were broadly eliminated from the culture.
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Figure 4.1: PA317 Cell Inserts used in the Generation of Retroviral Vectors for
Keratinocyte Transduction. The PA317 fibroblast cell genome contains two sequences.
The PA317 Cell Retrovirus Insert (top) is the genome of a deleted helper virus
incorporated into the genome of the PA317 fibroblast cell, and supplies proteins Gag,
Pol, and Env in trans for use in retrovirus generation. The helper virus genome also lacks
a packaging sequence (ψ), preventing its transcript from being packaged into the mature
retrovirus virions. A portion of the helper virus 5′ LTR is also missing to prevent
recombination events between the two sequences. The vector (bottom) incorporated into
the PA317 cell genome contains a packaging signal so that its transcript will be
incorporated into mature retrovirus virions, as well as genes that will be inserted into the
genome of a successfully transduced cell (up to 4 kb in length). The retrovirus insert
contains a SV40 polyadenylation signal to replace the 3′ LTR so as to prevent
recombination and also block second strand synthesis. TAG indicates the gag start codon
in the bottom vector sequence has changed to a stop codon. Arrows indicate transcription
start sites; LTR, the retroviral long terminal repeat; pA, the replacement of the 3′ long
terminal repeat with a Simian Virus 40 polyadenylation signal. Adapted and modified
from Miller, A. D., Molecular Therapy, 2002. Figure created with BioRender.com.
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Figure 4.2: Effect of HPV16 E6 and E7 Oncoproteins on Tumour Suppressor
Proteins. E6 oncoprotein binds to tumour suppressor protein p53, promoting its
degradation. E7 oncoprotein binds to tumour suppressor protein retinoblastoma (pRb)
while it is complexed with the E2 transcription factor (E2F), causing the release of E2F
and subsequently cell cycle activation. Adapted and modified from Ruttkay-Nedecky et
al, International Journal of Oncology, 2013. Figure created with BioRender.com.

Cells were retained pre-transduction as well as post transduction for comparison to one
another. This comparison would verify the donor’s isolated keratinocytes were not
previously infected with HPV16 before the study commenced, which could impact the
isolated keratinocytes phenotype in a non-controlled way. Additionally, this confirms
successful cell transduction through amplification of the viral insert.
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Transduced keratinocytes were subject to PCR analysis to verify the presence of the
HPV16 E6E7 insert in the keratinocyte genome155. Non-transduced and transduced
keratinocytes were compared by PCR amplification of the E6E7 sequence and resolving
any produced amplicon by gel electrophoresis. Additionally, verification of amplicon
identity (Figure 3.1) through sequencing and comparison to the viral insert in silico was
used to verify presence of the correct sequence. Transduced keratinocytes (Figure 3.2)
showed sharp bands at 773 base pairs, indicating successful integration of the HPV16
E6E7 sequence into their genome. Non-transduced, matched keratinocytes lacked any
bands in their respective lanes of the agarose gel (Figure 3.2). This suggests cells were
successfully transduced and possibly immortalized for this project. It is, however,
possible that the viral insert was not present in the non-transduced cell lanes of the
agarose gel due to degradation of isolated genomic DNA or PCR amplicon. Future
comparisons could include a housekeeping gene in the keratinocyte genome like βGlucuronidase (GUSB) to verify the presence or absence of PCR product in each lane of
the agarose gel185. As well, it is possible that these cells are not fully immortalized
despite introduction of the E6E7 sequence. The retroviral vector (based off of Moloney
Murine Leukemia virus) used in this study does not introduce the E6E7 insert into a
specific part of the keratinocyte genome; instead, there are weak preferences for insertion
into gene coding regions and strong preferences for transcription start sites and CpG rich
regions raising the possibility that it is introduced into a non-transcribed region186. This is
hopefully mitigated by rigorous selection in Geneticin antibiotic. Western blotting could
be used to detect E6, E7, and downstream proteins (e.g., pRb, hTERT, p53) in the cell
lysate to help confirm successful transcription and translation of functional proteins.
However, alternative approaches may be better suited for this project. E7 protein can
disrupt skin barrier integrity through altering claudin expression (an important epithelial
barrier aspect investigated in this study)187. As well, at later cell passages E6 and E7
oncoprotein immortalization disrupts the karyotype of the cells, while earlier passages
retain low tumourigenicity and have karyotypes similar to that of non-immortalized
cells188. Modulation of rEGF concentration in culture medium may increase keratinocyte
primary cell longevity up to 20 passages without immortalization as shown by Ahmed et
al, 2006 in ovarian epithelial cells189,190. As well, culture of keratinocytes could be
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conducted in the presence of the Rho kinase inhibitor Y-27632 which has been shown to
extend the neonatal foreskin keratinocyte passage number to 150191,192. These methods
could permit the mass culture of primary non-transduced keratinocytes required for skin
model development. In contrast, a different system of cellular immortalization could be
used that does not rely on HPV16 E6 and E7 proteins. Most importantly, these would
need to inactivate tumour suppressor genes involved in inducing cellular senescence193.
As suggested by Matsumura et al, 2004, the use of SV40 T antigen alongside
overexpression of the hTERT catalytic subunit can be effective at inducing cell
immortalization194. Additional alternatives include p53 siRNA expression while
overexpressing the hTERT catalytic subunit195,196. This also provides a more defined
genetic background that mimics keratinocytes with finite proliferative capacity195,196. Of
interest, keratinocytes could be grown, in the future, on a soft culture substrate to help
cells retain their stem-like phenotype197. Substrates such as polydimethylsiloxane
(PDMS) are less stiff than tissue culture plastic and have been demonstrated to reduce
premature keratinocyte senescence when the Young’s elastic modulus for the substrate is
either 1.5 or 15 kilopascals (kPa)197. This could provide a cell culture substrate-based
alternative to immortalization techniques discussed earlier.
Although not used to generate organotypic foreskins in this thesis, I have generated three
sets of paediatric transduced keratinocytes and banked these alongside matched nontransduced keratinocytes and fibroblasts. In the future, these will permit (1) creation and
testing of organotypic foreskins using these paediatric cells, providing a better match
comparator to the paediatric tissues and explants used in this study; (2) comparison of
organotypic models generated using immortalized and non-immortalized cells to
determine the effect of immortalization on key aspects of innate immunity and barrier
function; and, (3) investigation and comparison of alternative immortalization approaches
to current methods through use of non-transduced cells. Furthermore, during my thesis
adult keratinocytes from one additional individual were transduced and banked alongside
matched fibroblasts. These additional banked cells will allow for the creation of
additional organotypic foreskins that can be used in to bolster biological replicates in the
current work. Finally, these banked adult and paediatric cells can be used to determine if
there are any differences in innate immune function, tissue structure, or barrier function
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between organotypic foreskins generated from adult and paediatric tissues. This
information is important, as while adult skin in a more relevant model for sexually
transmitted infections, paediatric foreskins are substantially more readily available than
adult foreskins.

4.3

Generation of the Organotypic Foreskin Model

Artificial foreskin tissues were created as described in Gangatirkar et al, 2007, with
modifications made through troubleshooting highlighted in Table 3.6154. As can be seen
in Figure 3.3, fibroblasts are actively remodeling the collagen matrix they are placed in,
qualitatively observed through collagen gel contraction. The fibroblasts can be viewed
through phase contrast microscopy at all stages of model development, although this
becomes progressively more difficult to do so when keratinocytes start to proliferate on
the collagen surface and reduce light penetration. Initially, cellular collagen contraction
was minimal, and fibroblasts were quite sparse within the collagen hydrogel. Fibroblast
cell concentration was thus increased from 2.30 x 105 cells/mL to 3.28 x 105 cells/mL
(~105 cells/mL increase) during casting. This notably increased collagen contraction such
that the hydrogel decreased by 1/5th of its original size (contraction of approximately 1520%), and increased fibroblast density when viewed by phase contrast microscopy. While
these fibroblasts can be viewed through phase contrast microscopy, they are difficult to
resolve through immunofluorescent microscopy as there are few blue stained nuclei
present within the dermal mimic (Figure 3.4). In this comparison, there are many nuclei
shown within the in vivo dermis, while the dermal mimic of the organotypic tissue has
only one observable nucleus. While this may indicate reduced organotypic dermal
fibroblasts, many of the cells identified in the dermis in vivo are immune cells160, which
are absent in the organotypic tissues at this point in time. To accurately compare the
number of fibroblasts in the organotypic model to in vivo tissue, future comparison could
include immunostaining for vimentin, a cytoskeletal marker expressed within
fibroblasts198,199. However, vimentin is not specific for fibroblasts and is also expressed
within macrophages, T cells, and neutrophils in the dermis198–201. By combining
immunostaining for immune cell markers such as CD3, CD4, CD14, CD1a, langerin,
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CD1c, CD141, CD68, and CCR5 with vimentin, we could more accurately delineate the
immune cell populations of in vivo tissue from that of fibroblasts198,202–205. If complexed
with Haematoxylin and Eosin (H & E) staining, this may help provide an additional layer
of confidence in fibroblast identification by eliminating other cell types based on
morphology or staining patterns199. Once immune cell populations are added to the
organotypic tissue model, this combination of immunostaining and H & E staining could
help visualize the resident cells of the artificial dermis.
Keratinocytes, once added to the dermal mimic surface, form a confluent monolayer as
the apical surface becomes opaque and white in colouration (in sharp contrast to the
reddish-pink collagen surface; Figure 3.3C). Initially, I was only able to generate dermal
mimics with patches of keratinocytes located on their apical surface, but modification of
seeding and culture protocols allowed for confluent monolayer development. Initially,
cells were added in a single small volume (30 µL), high cell concentration (1.667 x 106
cells/mL) droplet to the surface of the collagen layer. Cells did not spread across the large
surface area of the collagen gel, and as such they often formed a small, centrally located
cell aggregate on its surface. This was due to the central location of the cell droplet, and
immediate culture in Epidermalization Medium meant to allow the cells to stratify.
Adding multiple small-volume (10 µL) cell droplets across the surface of the hydrogel,
increasing their concentration by one order of magnitude, and culturing the cells for one
week in K-SFM Complete medium allowed cells to attach to the gel, grow to form
colonies, and spread across the gel surface. This resulted in an almost confluent
monolayer consisting of multiple large patches of cells visible to the naked eye. To
further optimize this, keratinocyte culture time in K-SFM Complete was extended to 10
days to allow further proliferation (fully confluent monolayer shown in Figure 3.3C).
The fluorescence image of the mature organotypic foreskin in Figure 3.3D shows
formation of a multilayer epithelium on the surface of the dermal equivalent collagen, as
can be seen by multiple nuclei throughout the epidermis. The structural junction protein
E-cadherin is also located in this area, which suggests formation of functional adherens
junctions206–208. Finally, terminally differentiated keratinocytes appear present on the
apical organotypic model surface due to positive staining for filaggrin61–63.
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Representative images of foreskin tissue immediately frozen after surgery and an
organotypic foreskin were compared at higher magnification in Figure 3.4. Organotypic
foreskins are indeed composed of a multilayer epithelium and express E-cadherin and
filaggrin proteins in regions similar to that of in vivo foreskin tissue. Based on cell
morphology and the presence of filaggrin staining in the stratum corneum, it is possible
to identify the layers of the epithelium as each layer contains cells of distinct shape
(discussed in Chapter 1). These layers are clearly identified for the in vivo tissue shown in
this figure, which shows the stratum basale, spinosum, granulosum, and corneum as
expected. Cell morphology in the organotypic model is more difficult to visualize due to
the diffuse cytoplasmic and membrane localization of E-cadherin throughout the
organotypic tissue, whereas in vivo tissue E-cadherin is localized to the cell membrane.
This does not permit close comparison of cell morphology necessary to identify each
unique layer of the epithelium. However, stratum corneum location can be inferred
through the apical presence of the protein filaggrin and by the location of the stratum
basale (indicated by the presence of cuboidal cells at the clearly defined dermalepidermal junction). This limits identification of the stratum spinosum and granulosum.
Immunostaining the organotypic tissue with antibodies specific for early and late
keratinocyte markers of proliferation would help in identifying each distinct layer more
accurately and clearly209. Early markers of proliferation include cytokeratin 14 which is
expressed in the cells of the stratum basale, as well as cytokeratin 10, found in the
stratum spinosum and granulosum209. Late markers include cytokeratin 2 found in the
upper spinous and granular layers, and involucrin found in early stages of keratinocyte
terminal differentiation209,210. While this helps resolve the basal and apical layers, it still
makes identification of the stratum spinosum and granulosum difficult as there are no
markers specific to their constituent cells209. Optimizing the organotypic foreskin culture
may help localize E-cadherin expression to the cell membrane and aid in epidermal layer
visualization.
This pattern of immunostaining could additionally be a result of the increased duration of
formalin fixation necessary for preparing organotypic foreskin tissues for cryosectioning.
This is undertaken as collagen hydrogels have a high water content, which results in a
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hardness differential between the hydrogel and freezing medium it is embedded in211. As
observed in preliminary work, formalin fixation over 24 hours seemed to result in diffuse
E-cadherin immunoreactivity in immediately frozen in vivo foreskin when compared to
non-fixed immediately frozen foreskin. Replacement of formalin with a different fixative
or empirical testing of varied fixation times and formalin concentrations may remedy this
issue. Alternatively, tissues could be placed into ascending concentrations of sucrose
solution while still in culture, then a mixture of sucrose and OCT212. This renders the
frozen hydrogel homogenous with OCT and reduces the hardness differential between the
two substances212.
Lastly, E-cadherin is expressed at the organotypic foreskin apical and lateral surfaces
weakly, but strongly at the basal surface. This is in contrast to apicolaterally expressed Ecadherin in the in vivo tissue. If not an artefact of tissue fixation, this could indicate that
diffuse expression is due to altered cell signaling pathways important for localization of
structural junction proteins213–215. This is important for model development as in vitro
studies have indicated E-cadherin mediated adhesion between cells is a prerequisite in the
formation of tight junctions and desmosomes, with tight junctions specifically examined
in this study213,214. Future study is necessary to discern the exact reason for this
observation and to implement corrective measures, such that the organotypic tissue model
may more accurately mimic in vivo skin.
The COVID-19 pandemic substantially disrupted the availability of tissues during this
project. As a result, paediatric tissues were used for explant and immediately frozen
comparators to organotypic foreskins generated with cells isolated from adults. To
determine if this was an appropriate comparison, different tissue parameters were
compared between paediatric participants and one adult foreskin tissue available (Figure
3.5). In these graphs, it is shown that immediately frozen paediatric inner and outer
foreskin tissues showed no difference in their overall thickness for the E-cadherin layer,
filaggrin layer (stratum corneum), or the total epithelium as defined by the pipeline used.
Preliminary results for adult tissues suggest that they may show some difference in inner
and outer foreskin thickness for the E-cadherin, filaggrin, and total epithelial layers
compared to each other and paediatric tissues. Additional adult and paediatric in vivo and
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organotypic foreskins are necessary to draw accurate conclusions about use of
comparator groups in this and future studies.
When quantifying tissue parameters between in vivo, explant, and organotypic tissues as
in Figure 3.6, it is clear that the organotypic model is composed of cell layers that express
the protein E-cadherin (Figure 3.6A), as well the protein filaggrin (Figure 3.6B). It is also
able to produce multiple layers of cells similar to that of the in vivo epithelium, as
revealed through measuring the total epithelial thickness (Figure 3.6C). However, one
difference observed is that, while the organotypic model had a layer of E-cadherin as
thick as in vivo tissue, it had a much thicker filaggrin layer, resulting in greater overall
epithelial thickness. A thicker organotypic filaggrin layer may be due to reduced
desquamation due to a lack of physical abrasion in culture, compared to what in vivo skin
would experience. More biological replicates are required to draw statistical conclusions
from these results (Figure 3.6) and be able to compare between tissues examined. One
limitation in the E-cadherin thickness measure is the presence of rete ridges at the
dermoepidermal junction in in vivo tissue. These are not present in organotypic tissue,
simplifying the depth measurement, but their presence within in vivo tissue limits
quantification as they may occur at higher frequency in some parts of the tissue than
others. It may be more accurate to determine the median depth of each in vivo FOV and
separate each depth into quintiles and determine which quintile the organotypic model is
most comparable to. As well, paediatric organotypic foreskins need to be generated to
compare to adult organotypic foreskins. This comparison could, in the future, determine
the feasibility in comparing organotypic foreskins to either adult or neonate tissue.
Lastly, organotypic tissue may produce more E-cadherin than that of in vivo tissue,
although this again cannot be confidently said due to lack of biological replicates
amongst both groups, and the diffuse cytoplasmic localization of E-cadherin throughout
the organotypic tissue. In contrast, seven-day explant cultured tissue contained large
holes throughout its suprabasal epidermal layers and poor immunoreactivity. Seven-day
cultured tissue loses its ability to maintain its architecture at some point during the culture
period, while also losing expression of E-cadherin protein (Figure 3.6A, B, C, and D).
Thus, it can be shown through these preliminary results that organotypic foreskin tissue
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may be able to mimic in vivo tissue architecture and E-cadherin expression more closely
than seven-day cultured explant tissues.

4.4

Characterizing Innate Immune Capability

To examine innate immune capability, tissues were examined for: (1) mRNA expression
of TLR1, TLR2, and β-defensin-1 during culture and after challenge with TLR agonist
LPS; and (2) secretion of the chemokine IL-8 upon challenge with LPS. Expression of
mRNA for innate immune proteins was normalized to GAPDH, which has been shown to
be stably expressed in post mortem skin tissues216. GAPDH served as a measure of a gene
expressed at similar levels between cells, but while this may be similarly expressed in
explanted and fresh skin, it may not be in organotypic tissues. As well, there is a growing
trend in using more than one stably expressed reference gene when normalizing cell or
tissue level qPCR data185. While information regarding multiple reference genes for
analysis of human skin tissue is scarce, further selection and validation of reference genes
could be conducted in the future on both paediatric, adult, and organotypic foreskin
samples. By selecting a large enough number of similarly expressed reference genes, we
could ensure more accurate comparisons of normalized target mRNA across tissues
examined in this study.
To quantify the number of mRNA copies for TLR1, TLR2, and β-defensin-1, qPCR
experiments were optimized in terms of primer concentration and annealing temperature
using a synthetic double-stranded DNA oligonucleotide-based standard curve217. The
optimized mean reaction efficiency and linearity for each standard curve are shown in
Table 3.7. The mean efficiency for each (TLR1, TLR2, β-defensin-1, and GAPDH)
qPCR assay falls within the 90-110% efficiency guideline recommended for use of
absolute quantification218. The assay linear dynamic range was high for the qPCR assays
conducted as, aside from TLR1, each had a mean linearity greater than 0.995. In contrast,
the qPCR assay for TLR1 had a mean linearity of 0.991 ± 0.005. Often in absolute
quantification it is assumed that the standard and sample have the same efficiency, but
this may not be the case219. In the future, to assess if efficiency is similar between the

105

standard and samples (two different targets), samples can be serially diluted similar to the
oligonucleotide standard and the cycle threshold value determined per sample to establish
a sample-based standard curve. This will allow for direct comparison to the
oligonucleotide standard and permit troubleshooting should the sample-based standard
curve differ in efficiency.
There was no detectable difference in TLR1, TLR2, or β-defensin-1 mRNA abundance
between immediately snap frozen, seven-day cultured explant, and organotypic foreskin
tissues. It can be reasonably assumed from this that expression did not differ between the
cells of the tissue, but it is not known if mRNA examined was from living or apoptotic
cells. As highlighted before in analyzing tissue structure, the seven-day explant loses
tissue integrity and does not stain for E-cadherin (Figure 3.5, Figure 3.10). It is possible
that the rate of apoptosis in the explant differs from the other tissues. Differences in
induction of apoptosis may result in increases or decreases in mRNA yield per total
number of cells in the tissue. This may be due to global degradation of mRNA that occurs
near the initiation of apoptosis220. The presence of degraded intermediate mRNA of
different lengths from cells at different stages of apoptosis may artificially change the
quantity of mRNA copies of any of the genes examined in the study. This could be an
upward or downward change in the copies expressed per 10,000 copies of GAPDH,
depending on which target mRNAs have started degrading within the tissue sample. It is
integral, in the future, that matched tissues be immunostained for markers of apoptosis
such as apoptosis regulatory proteins caspase-3, B-cell lymphoma 2 (Bcl-2), or p53221.
This will allow the amount of tissue level apoptosis in all tissues to be examined so as to
validate this assay. It is also possible that GAPDH mRNA copies are decreasing within
the seven-day explant, leading to increased target mRNA copies when normalized to it.
This could be remedied by including more reference genes and comparing GAPDH
numbers across fresh and seven-day tissues. We could alternatively immunostain foreskin
tissue sections or perform Western blotting to determine protein level expression of TLRs
or β-defensin-1.
Additionally, there was no detectable difference in expression of TLR1, TLR2, or βdefensin-1 mRNA copy numbers between fresh cultured, seven-day cultured explant, and
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organotypic tissues stimulated with LPS and their matched unstimulated controls. Once
more, careful analysis of stimulated and non-stimulated tissues at matched time points for
markers of apoptosis is necessary to verify the identity of the population of cells
examined in this analysis. One limitation experienced when stimulating organotypic
tissues is the dispersion of aqueous LPS on their large, dry apical surface. While LPS
covered the moist explant apical surface, the droplet added to the organotypic model did
not seem to disperse on the surface of the tissue. This acts to limit the amount of tissue in
contact with the LPS, and therefore may result in a reduced or minimal response from the
organotypic tissue. Future directions include scaling the LPS droplet volume up such that
it matches the droplet/surface area ratio of the explant tissue and ensuring the organotypic
tissue surface area is in full contact with LPS. Lastly, examination of β-defensin-1 could
be complemented with that of β-defensin-2, which has been shown through Northern
blotting to sometimes upregulate in expression upon fresh skin tissue exposure to LPS222.
It may be possible that LPS alone is not sufficient to induce expression of the genes
examined, and that additional stimulatory factors (like the cytokine IL-1) are necessary
for this as these factors are also required in some cases for β-defensin-2 expression222.
Tissues were then examined for their ability to respond to stimulation with the TLR4
agonist LPS through quantifying secretion of the chemokine IL-8148,223. Fresh foreskin
tissue obtained after circumcision surgery, tissue cultured in medium for seven days, and
organotypic foreskins were exposed to a 100 ng/mL solution of LPS in endotoxin-free
water, with culture medium harvested and tested for IL-8 (Figure 3.9). At 6 hours (Figure
3.9A), fresh paediatric tissue did not secrete detectable IL-8 (lower limit of quantification
= 15.6 pg/mL; limit of detection = 2.0 pg/mL), regardless of LPS exposure, while IL-8
secretion was upregulated at 12 and 24 hours regardless of LPS exposure. This is in
contrast to seven-day explanted tissue, which produced similar IL-8 levels regardless of
IL-8 exposure throughout the entire 24-hour time period (Figure 3.9B). In sharp contrast
to both fresh tissue and seven-day explants, the LPS-stimulated organotypic model
secreted more IL-8 at the 6-hour time point relative the unstimulated tissue. IL-8 levels
increased to similar levels across stimulated and non-stimulated tissues past 6 hours.
Additionally, IL-8 levels decreased over time in comparison to the cultured explant
tissues, suggesting it was downregulated after peaking at 12 hours of LPS exposure.
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These results could be the due to the presence of microbiota-associated bacteria on the
fresh and possibly seven-day explant tissues, which would be absent from the sterile
organotypic foreskin tissues. Fresh tissue explants were not transported or cultured in
media containing antibiotic after surgery. It is possible that bacteria still present during
culture modulated IL-8 secretion, similar to what occurs during multi-species biofilm
formation in gingival tissue (a stratified squamous epithelium just like the foreskin)224.
As a result, our measures of IL-8 secretion for fresh tissue after the first six hours could
be artificially elevated due to possible bacterial overgrowth or biofilm formation, limiting
our ability to compare to seven-day explants and the organotypic foreskin. The seven-day
cultured explant tissue was cultured in medium containing antibiotics for the seven-day
culture period to limit bacterial and fungal overgrowth, but residual biofilm-associated
bacteria may remain during this period and modulate IL-8 secretion. The organotypic
tissue was sterile at baseline, which may explain the large increase in IL-8 compared to
the other models at the 6-hour time point. This suggests the organotypic foreskin could be
used to study the effects of microbes on the foreskin tissue, as the organotypic foreskin is
sterile during culture and is not influenced by microbiota-associated bacteria unless it is
artificially inoculated or loses sterility. For future assays, foreskin tissue could be
transported from the surgical site to the laboratory in a bactericidal and fungicidal
antibiotic-antimycotic solution such as Primocin. Tissue could then be washed several
times before use with 1X DPBS, which in combination with antibiotic-antimycotic
exposure could eliminate a proportion of the patient’s bacterial and fungal microbiota and
any possible undesired tissue immune modulation. We could also swab foreskin tissue
explants after antibiotic-antimycotic treatment and determine the residual microbial load
prior to conducting the assays described within this study.
In the future, comparing the function of TLR4 to mRNA expression and protein levels
may help discern if changes in expression are related to altered function across tissue
types. While data has been generated for gene expression of TLR1 and 2, it has not been
for TLR4. Western blotting or immunofluorescent microscopy may also help in
quantifying tissue protein expression for different TLRs and relating it to gene
expression.
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4.5

Characterizing Tissue Barrier Function

Tissue barrier function was analyzed using several different methods. First, immediately
frozen and explant cultured tissues were examined for the presence of tight junction
protein claudin-1. The amount of immunoreactivity per immunofluorescence image was
then quantified in silico between adult and paediatric tissues. This was repeated on tissues
stimulated with a 100 ng/mL solution of LPS, to examine if experimental TLR4
stimulation could enhance production of barrier proteins. Enhancement of the epidermal
barrier occurs with peptidoglycan-mediated TLR2 stimulation on cultured keratinocytes,
prompting this investigation225. Lastly, a permeability assay was conducted on fresh,
seven-day cultured, and organotypic tissues to establish the functionality of tight
junctions in each tissue226.
Immunofluorescence imaging of foreskin immediately frozen after surgery alongside
cultured explants demonstrated that over culture time, organized tissue architecture and
integrity was lost (Figure 3.11). After one day of culture, fresh tissue appeared to develop
multiple holes within the suprabasal epidermis, which was enhanced in seven-day
cultured tissue regardless of LPS exposure (Figure 3.11A, B, C, D). Seven-day cultured
explant tissue appeared to have fewer nuclei in the suprabasal epidermis when compared
to immediately frozen and fresh cultured tissues, which could be indicative of cell
migration or death during the culture period. With previous organotypic foreskins, poor
cell surface localization of E-cadherin prompted us to subject these organotypic cultures
to short, low RPM shaking to replicate shear stress and possibly enhance cell-cell
adherens junction formation. This was prompted through examining studies showing that
microflow-induced shear stress modulates keratinocyte physiology and enhances Ecadherin and ZO-1 colocalization at the cell-cell junction227–231. Regrettably, organotypic
cultures subject to mechanical agitation did not exhibit definable tissue structure (Figure
3.11E). Lastly, claudin-1 immunoreactivity qualitatively decreased and was nearly absent
in the majority of seven-day cultured explant tissues compared to fresh tissue (Figure
3.11A, C). This was in contrast to LPS stimulated fresh tissue and seven-day explants,
which appeared to retain claudin-1 immunoreactivity in some portions of the tissue
(Figure 3.11B, D). Mechanically agitated organotypic foreskins did not exhibit
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quantifiable (through our methods) claudin-1 immunoreactivity, with immunoreactivity
appearing diffuse and non-specific. Explant cultures may, over time, start to lose
functional tight junction protein claudin-1 which could be due to cell migration from the
tissue. Previous publications have reported that, over the first few days of explant culture,
keratinocytes migrate away from the tissue, soon followed by fibroblasts, which begin
migration several days later152. Cell migration itself is facilitated by forming new
adhesive connection to other cells and substrate while reducing previous connections232.
Consequently, the non-uniform expression of adhesion proteins within a tissue due to
migration (e.g., desmosomes, tight junctions, and adherens junctions) may alter
permeability of the tissue itself232. During our study, organotypic foreskin did not show
robust claudin-1 expression presumably due to mechanical agitation, severely reducing
the ability to make comparisons between other tissues. Despite this, it can be seen that the
non-mechanically agitated organotypic model can express E-cadherin in a similar way to
that of immediately frozen tissue (Figures 3.4 and 3.10). Expression of E-cadherin is also
qualitatively and quantitatively maintained within organotypic foreskins while that of
seven-day tissue is lost, suggesting that cells are migrating away from explant cultured
tissues while they are not from organotypic foreskins. Further investigation, such as by
analyzing tissue cell populations through culture, is necessary to draw this conclusion.
Next, there was no detectable difference in claudin-1 immunoreactivity between
paediatric inner and outer tissues (Figure 3.12A, B, E). Additionally, adult inner and
outer foreskin tissues may show differences in expression between one another and
paediatric tissues, but more biological replicates are required to confidently determine
this (Figure 3.12C, D, E). It could be possible that similarity in claudin-1 expression
between paediatric participants and differences shown between the adult participant is the
result of age differences or puberty. Paediatric participants included in this analysis were
of median age 8.17 yrs (range: 1.78 – 14.15 yrs), only one was within the range at which
puberty begins, and all had phimosis (Table 3.4). This is in sharp contrast to the adult
participant (Table 3.3, ADLT 009) who has gone through puberty and, although not
before surgery, may have been able to retract their foreskin. Careful analysis of these
factors and the role they play may be able to determine the reasoning for any differences
exhibited between and within adult and paediatric tissues.
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Fresh, seven-day explant cultured, and organotypic foreskin tissues were then subject to
qPCR to detect claudin-1 mRNA copy numbers. This was performed so as to evaluate
culture effects on claudin-1 expression. Additionally, this analysis was performed using
the same tissue types but stimulated with LPS, as well as matched unstimulated controls
to examine if TLR4 stimulation could upregulate claudin-1 gene expression as
peptidoglycan can by stimulating TLR2225. The qPCR assay was optimized such that the
mean efficiency was between 90-110% and linearity greater than 0.995, which ensured
accuracy and guaranteed reaction efficiency fell within recommended guidelines for use
of absolute quantification (Table 3.8)218. Over culture, expression of claudin-1 did not
change between fresh cultured, seven-day cultured, and organotypic tissues (Figure 3.13).
As mentioned previously, the population of cells in the tissue analyzed via qPCR must be
verified as non-apoptotic so as to ensure the measure obtained is an accurate
representation of tissue gene expression and not skewed by the presence of apoptosisinduced mRNA degradation intermediates. It is also, as mentioned previously, possible
that GAPDH mRNA copies decrease within the seven-day explant which could skew
normalized claudin-1 transcript numbers. This could be remedied by including more
reference genes and comparing GAPDH numbers across fresh and seven-day tissues.
There was additionally no detectable difference in claudin-1 mRNA copies in fresh,
seven-day cultured explant, and organotypic tissues exposed to LPS and their matched
tissue controls (Figure 3.14).
Tissue permeability was quantified through use of a dextran tracer exclusion assay.
Dextran was chosen as the molecule to examine permeability as it is a non-digestible
sugar that is not known to undergo transcytosis by epithelial cells226. Pinocytosis of
dextran has been reported by epithelial cells, but this is negligible due to its slow rate in
comparison to paracellular transport226. As can be shown in Figure 3.15A, time was a
significant predictor of seven-day explant permeability, but not fresh tissue permeability.
This could be due to tissue integrity and barrier function loss as noted earlier which could
be the result of cell migration out of the seven-day explant tissue, but not fresh tissue. Of
note, one participant had significantly more permeability at 12 and 24 hours (PED 041:
age 8 yrs, African American) than the other two (PED 040: age 14 yrs, Caucasian; PED
037: age 9 yrs, Caucasian) in each grouping. Each participant underwent circumcision to
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treat phimosis during this study. These data raise the question that participant ethnicity
may be correlated to permeability measures (in comparison to age or indication for
circumcision), which could restrict tissue comparisons from paediatric participants of
different ethnicity. To discern whether or not this is the case, it would be necessary to
have a larger sample size and more information on ethnicity. This could help ensure
better generalizability of results in the future when generating foreskin models from
different ethnic groups.
In contrast, time was a significant predictor of organotypic foreskin permeability. When
examining the two organotypic tissues used in this experiment, it can be noted that ADLT
001 had lower permeability at all timepoints compared to ADLT 002, suggesting there
may be donor-to-donor variability even in the organotypic model. These data also suggest
that the organotypic model has relatively poor barrier function. However, this poor
function may be due to mechanical agitation of the tissues during culture, and not
reflective of the model if grown statically. Mechanical agitation most likely disrupted the
structure of the tissues examined, as can be shown in immunofluorescence images of
ADLT 001 and 002 (Figure 3.15B and C, respectively). Restricting mechanical agitation
to the end stage of development (culturing in maintenance medium) or replacing it with a
surface level fluid microflow may reduce integrity loss and enhance tight junction
expression and localization231. As well, the passage number of the cells used to generate
organotypic models may influence permeability, as it is known that HPV16 E6E7
immortalized cells may display altered karyotypes at high passage numbers188. ADLT
001 was seeded with passage 14 keratinocytes, while ADLT 002 was seeded with
passage 10 keratinocytes. It is also possible that HPV16 E7 expression in immortalized
cells altered tight junction expression, and may have reduced the ability to form a
functional, sealed epithelial barrier even without mechanical agitation187. Investigation
into alternative immortalization techniques may be necessary to remedy this.
Based on these results, the tracer exclusion experimental technique has been optimized to
the extent that it that has the possibility discriminate between optimal and suboptimal
barrier functionality (i.e., distinguish between participants organotypic foreskin tissues
and between fresh and seven-day explant tissues). Once additional organotypic foreskin
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tissues are produced, this method can be used to screen them for permeability next to
matched explant tissues to examine any differences in overall barrier function.

4.6

Future Long-Term Directions

In order to refine the organotypic foreskin tissue model and allow it to more closely
mimic in vivo foreskin tissue, many different short- and long-term goals need to be met.
While short-term goals are listed within this discussion already, this section will focus
those in the long-term.
To enhance the tissue-level accuracy of the organotypic foreskins, several different
approaches could be undertaken. First, additional cells like melanocytes could be
incorporated in the tissue model where appropriate. Melanocytes, for example, could be
added to the keratinocyte cell suspension and seeded onto the cellularized collagen
described in the study. Second, the organotypic foreskin tissues could be cultured using a
medium perfusion system similar to that established by Strüver et al, 2017233. This
system, when used with our foreskin models, may supplement diffusion-based medium
feeding by providing convection effects to the basal aspect of the tissue. As well, the
continual flow of medium against the basal aspect would transmit mechanical stress to
the tissue model, which could augment mRNA and protein level expression of skin
structural and barrier markers.
While tissue structure is an important aspect to modify in the future, another significant
facet of this work will be the incorporation of immune cells with the foreskin tissue
model to facilitate the study of tissue-microbiota interactions. This will be a challenging
aspect, involving the isolation, independent culture, and then integration of immune cells
with the organotypic foreskin dermal layer and basal medium. Technically, this will
require knowledge of how to culture multiple different cell types each with their own
varying culture conditions (e.g., fibroblasts, keratinocytes, melanocytes, and varying
subsets of immune cells). It will also require isolation of immune cells (that differ in
frequency within the blood) from same-participant blood samples, requiring large
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aliquots of blood to facilitate the extraction process. As well, this aspect will require
seeding immune cells at physiologically relevant densities in the foreskin model. Once
the immune cell integration process is completed, it will be followed with incorporation
of microbes on the tissue model, and eventually replication competent HIV.
When incorporating the microbiota, it will be of interest to examine possible differences
that high and low HIV risk microbiota induce on organotypic foreskins that contain
immune cells. This could help delineate microbiota-based differences in foreskin immune
activation. As well, inoculating suspect bacteria onto the organotypic foreskin cultures
would help solve the issue of bacterial co-occurrence that has obscured study of the exact
species of anaerobes implicated in uncircumcised heterosexual male HIV susceptibility.
Lastly, high HIV risk bacterial species could be examined in studies looking at
microbiome alteration using the organotypic foreskins generated in this study. Narrow
spectrum pharmacologic agents could be developed and initially tested on the foreskin
model to examine their effect on eliminating high risk bacteria. As well, study on the
effects of microbiota supplementation or transplantation could be conducted to see if one
can alter the penile microbiota through this approach, compared to alternatives like
circumcision or topical antimicrobial use.
The tissue model could also, if an artificial hypodermis is incorporated similar to
Sugihara et al, 1991, be used for the formation of full skin equivalents and used for study
of the microbiota on other portions of the body234. This organotypic full skin equivalent
could possibly, with modification and significant testing, be used as a treatment modality
for deep skin injuries (e.g., chronic ulcers).
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Chapter 5

5

Conclusion

In vitro organotypic foreskins have been generated and compared to foreskin tissue
frozen immediately after circumcision and seven-day cultured explant tissues.
Organotypic foreskins form multilayer epithelia capable of expressing E-cadherin (an
adherens junction protein) as well as filaggrin (a marker of keratinocyte terminal
differentiation). More work is required to compare the stratification of organotypic
tissues to that of explant cultured tissues and ensure they are able to mimic the unique
epidermal layers present in stratified squamous keratinized epithelia. Organotypic tissues
were also shown to express genes for innate immune sensors TLR1 and TLR2, and the
antimicrobial peptide β-defensin-1. Similar to fresh and seven-day explant tissues,
organotypic tissues did not alter expression of these innate immune genes when
stimulated with LPS. However, in contrast to fresh and seven-day explant tissues,
organotypic tissue appeared to increase secretion of the chemokine IL-8 in response to
LPS stimulation, although these results are preliminary, and more replicates are required
to confidently state this. Lastly, a method to reliably discern optimal and suboptimal
tissue barrier function has been optimized for use with organotypic tissues. Preliminary
permeability results indicate mechanical agitation during maturation leads to poor tissue
structure and high permeability of organotypic foreskins, and that seven-day explants
have reduced barrier function compared to fresh tissues. Further investigation of tissue
permeability in relation to mechanical agitation and current immortalization techniques is
required to discern whether these play a role in altered organotypic foreskin barrier
function.
While more work is required to improve this tissue model, the organotypic foreskin
model described does present a promising option for exploring the effects of long-term
culture with foreskin anaerobes on foreskin innate immunology. Preliminary results
suggest organotypic foreskin tissues provide a physiologically relevant environment for
the culture of the foreskin microbiota (a dry, cornified surface that is sterile prior to
inoculation). As well, preliminary evidence suggests organotypic foreskins retain
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expression of innate immune mediators, as well as adherens junctions that play a role in
maintaining tissue structure. This is in contrast to foreskin tissue cultured for seven-days,
which loses tissue integrity and does not provide a dry, sterile environment to inoculate
the foreskin microbiota for long-term culture.
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Appendix A: Statements of Approval for the Use of Human Tissues in Experimental
Research.
All experimentation using human subjects was performed in compliance with protocol
111054 and 113008 (below) held by Drs. Eric Arts and Jessica Prodger, principal
investigators at the University of Western Ontario Schulich School of Medicine and
Dentistry, Department of Microbiology and Immunology, London, Ontario, Canada.
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